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A growth factor–expressing macrophage
subpopulation orchestrates regenerative
inflammation via GDF-15
Andreas Patsalos1, Laszlo Halasz1, Miguel A. Medina-Serpas1, Wilhelm K. Berger1, Bence Daniel1, Petros Tzerpos2, Máté Kiss2,
Gergely Nagy2, Cornelius Fischer3, Zoltan Simandi4, Tamas Varga2, and Laszlo Nagy1,2
Muscle regeneration is the result of the concerted action of multiple cell types driven by the temporarily controlled
phenotype switches of infiltrating monocyte–derived macrophages. Pro-inflammatory macrophages transition into a
phenotype that drives tissue repair through the production of effectors such as growth factors. This orchestrated sequence
of regenerative inflammatory events, which we termed regeneration-promoting program (RPP), is essential for proper repair.
However, it is not well understood how specialized repair-macrophage identity develops in the RPP at the transcriptional level
and how induced macrophage–derived factors coordinate tissue repair. Gene expression kinetics–based clustering of blood
circulating Ly6Chigh, infiltrating inflammatory Ly6Chigh, and reparative Ly6Clow macrophages, isolated from injured muscle,
identified the TGF-β superfamily member, GDF-15, as a component of the RPP. Myeloid GDF-15 is required for proper muscle
regeneration following acute sterile injury, as revealed by gain- and loss-of-function studies. Mechanistically, GDF-15 acts
both on proliferating myoblasts and on muscle-infiltrating myeloid cells. Epigenomic analyses of upstream regulators of Gdf15
expression identified that it is under the control of nuclear receptors RXR/PPARγ. Finally, immune single-cell RNA-seq profiling
revealed that Gdf15 is coexpressed with other known muscle regeneration–associated growth factors, and their expression is
limited to a unique subpopulation of repair-type macrophages (growth factor–expressing macrophages [GFEMs]).
Introduction
Tissues frequently undergo acute damage during an organism’s
lifetime. To maintain the body’s integrity and homeostasis, it is
critically important to achieve complete regeneration. In highly
regenerative tissues such as skeletal muscle, a straightforward
sensory-effectors paradigm is applied whereby organ injury
induces changes detectable by distinct cell types. These changes
lead to activation of effector mechanisms promoting expansion
and differentiation of a quiescent population of tissue-specific
stem cell–like progenitors. Strikingly, the immune system ap-
pears to have key roles in this process both as a sensor and as an
effector (Arnold et al., 2007; Yona et al., 2013; Chazaud, 2014;
Okabe and Medzhitov, 2014; Wang et al., 2014), which amounts
to regenerative immune response. Dysregulated injury-induced
immune response has been shown to impair regeneration in
several tissues such as the liver, central nervous system, or
skeletal muscle (Rapalino et al., 1998; Duffield et al., 2005;
Laflamme and Murry, 2011; Chazaud, 2014). Importantly, im-
mune cells, and in particular, monocyte-derived macrophages
(MFs), have a dual role during damage and regeneration
(Tidball, 2017; Chazaud, 2020). First, these cells sense and react
to the injury, remove necrotic debris, and then transition to
initiate restoration of tissue integrity as effectors via pro-
moting resolution of inflammation and repair mechanisms
acting on both the infiltrating immune cell population and
the regenerating stem cell pool. The widely accepted paradigm
about the two main MF populations posits that the initially
appearing lymphocyte antigen 6 complex (Ly6C)high MFs are
inflammatory, while Ly6Clow MFs are repairing in cellular char-
acter (Varga et al., 2013; Varga et al., 2016a). During the regen-
eration phase, Ly6Clow repair MFs secrete cytokines and growth
factors such as insulin-like growth factor 1 (IGF-1), GDF-3, IL-10,
and TGF-β that act in a paracrine and/or autocrine manner and
can contribute to the repair cell milieu (Fadok et al., 1998; Lu et al.,
2011; Deng et al., 2012; Tonkin et al., 2015; Varga et al., 2016b). It
is assumed that during this latter phase, the regenerative im-
mune response regulates the activation of tissue progenitor cell
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populations to support cellular growth and differentiation. It is
also likely that themicroenvironment and reciprocal inter-cellular
interactions mediated by local autocrine and paracrine mecha-
nisms are driving the inflammatory-to-repair phenotypic switch
(Patsalos et al., 2017). Our understanding is still incomplete on
howMFs change their phenotype, employ sensory and regulatory
mechanisms, and use effector functions to serve such complex
reparatory roles. This is particularly important because the proper
signaling between the participating cell types ensures the pre-
cisely timed progression of repair while avoiding asynchrony,
which can lead to delay, fibrosis, and chronic inflammation
(Tidball and Villalta, 2010; Dadgar et al., 2014). We sought to
identify novel integrated sensory, regulatory, and effector mech-
anisms and transcriptional programs equipping the relevant MF
subpopulations with the capacity to contribute to the timed pro-
gression of repair.
Here, we used the cardiotoxin (CTX)-induced skeletal muscle
injury model, which is a highly reproducible in vivo model of
sterile physiological inflammation (Hardy et al., 2016), to
carry out an unbiased transcriptomic analysis of the circu-
lating monocytes and the derived dynamically changing in-
filtrating MF subpopulations involved in regeneration. This
integrated time course–based profiling revealed several
transient, and remarkably, some sustained transcriptional
programs during the monocyte to inflammatory and then to
repair the MF continuum of cellular phenotypes. We iden-
tified growth/differentiation factor-15 (GDF-15; Bootcov
et al., 1997; Lawton et al., 1997), a secreted growth factor,
and a divergent member of the TGF-β superfamily. GDF-15 is
being induced and then steadily and continuously up-
regulated, reaching its highest level of expression in the
repair MF populations within injured muscles. Importantly,
mice with a hematopoietic deletion of Gdf15 showed a pro-
nounced delay in skeletal muscle regeneration and delayed
the inflammatory to repair subtype conversion of MFs. In
addition, we found that peroxisome proliferator–activated
receptor γ (PPARγ) and retinoid X receptor α (RXRα) regu-
lated the expression of Gdf15 at the transcriptional level
in repair MFs. Myeloid RXR deficiency impaired muscle
regeneration, and recombinant GDF-15 could enhance the
proliferation of primary myogenic precursor cells in in vitro
cultures and increase the expression of antigen-presenting
molecules in repair MFs in vivo. In summary, our data reveal
a novel integrated pathway in repair MFs with sensory,
gene regulatory, and effector components that includes the
RXR–PPARγ–GDF-15 regulatory axis that ensures the timely
onset and progression of regenerative inflammation dur-
ing skeletal muscle regeneration. This finding was further
corroborated and refined by single-cell RNA sequencing
(scRNA-seq) data revealing a novel and functionally dis-
tinct growth factor–expressing MF (GFEM) subtype within
the regenerating cell milieu, marked by growth factors
GDF-15, IGF-1, and GDF-3. These data identify the cellular
source and support a role for GDF-15 as a local, autocrine,
and paracrine signal that participates in sustained tran-
scriptional regeneration-promoting programs (RPPs) in repair
MFs during tissue injury.
Results
The dynamically changing transcriptional landscape during
in situ monocyte to inflammatory and repair MF transition
To provide an unbiased and robust foundation for our study, we
systematically profiled the in situ differentiation of circulating
blood monocytes to inflammatory Ly6Chigh and then to repair-
Ly6Clow MFs during sterile inflammation and muscle regenera-
tion with the goal of identifying distinct transcriptional patterns
across these two transitions (Fig. 1 A; reviewed recently by
Chazaud, 2020; Patsalos et al., 2021). In this model, sterile in-
flammation is caused by a single intramuscular CTX injection,
which in turn triggers severe muscle fiber death. The inflam-
mation is accompanied by a rapid and robust infiltration of
neutrophils and circulatingmonocytes, and the generation ofMF
subpopulations in the regenerating muscle comprising first
Ly6Chigh EGF-like module-containing mucin-like hormone
receptor-like 1 (F4/80)low and then Ly6Clow F4/80high subsets
(Varga et al., 2013; Varga et al., 2016a), which exhibit a dynamic
transition in cellular phenotypes (Fig. S1). The robust accu-
mulation of these MFs enabled us to profile these cellular subsets
by RNA-seq and extend the gene expression profiles, and analysis
of the muscle-infiltrating MFs we obtained previously using mi-
croarrays, and CX3CR1 (instead of F4/80) as a marker for infil-
trating MFs (Varga et al., 2016a; Varga et al., 2016b). More recent
studies by others (Arnold et al., 2015; Jin et al., 2018; Panduro et al.,
2018; Iavarone et al., 2020) used a similar gating strategy (Fig. S1)
but only for single time points (i.e., day 4 or 5 after CTX injury) or
by using different specialized markers like MGL1, CD64, MerTK,
and MHCII that characterize only certain aspects of the functional
spectrum of infiltrating MFs. The CTXmodel uses a standard time
course (days 1, 2, and 4 after injury) based on convention and
experience. Circulating monocytes were sorted (purity >98%)
according to their CD11b, Ly6G, Ly6C, and MHCII (H2-Eb1) ex-
pression (Fig. S1 A) andmuscle-infiltratingMFs according to CD45
(Ptprc), Ly6C, Ly6G, and F4/80 (Adgre1) expression at days 1, 2, and
4 after CTX injury (Fig. S1, B–D). mRNA expression of these
markers validates the purity and effectiveness of the sorting and
gating strategy (Fig. S1 E). Results obtained previously by our
laboratory (Varga et al., 2016a; Varga et al., 2016b; Patsalos et al.,
2017; Giannakis et al., 2019) and others (Arnold et al., 2007;
Mounier et al., 2013; Panduro et al., 2018) show that inflammation
and in particular the numbers of Ly6Chigh and Ly6Clow MFs in
regenerating muscle significantly decline after day 4 after injury
(Giannakis et al., 2019). During regeneration, the initial Ly6Chigh
F4/80low MF population (Fig. S1 B) rapidly disappears and gets
replaced by a population of Ly6Clow F4/80high MFs starting at day
2 after injury (Fig. S1 C), whereas the neutrophil infiltration is
cleared. 4 d after muscle injury, at a stage that is characterized by
active muscle regeneration, the Ly6Chigh population has almost
completely transitioned to a well-defined Ly6Clow repair pheno-
type (Fig. S1 D).
Principal component analysis revealed that muscle MFs
formed well-circumscribed groups, ranked according to their (1)
specific sorting markers (Ly6C high/low status) and (2) day of
isolation (Fig. 1 B). Day 1 and 2 Ly6Chigh MFs clustered closer,
whereas day 2 and 4 Ly6ClowMFs, as well as circulatingmonocytes,
clustered farther apart, corresponding to the proinflammatory
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Figure 1. Transcriptional changes during in situ monocyte to inflammatory and repair MF phenotype transition. (A) Experimental design overview.
Experimental setup used to study transcriptional dynamics in WT circulating monocytes and muscle-infiltrating MFs. Cell suspensions were collected from
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phase (days 1–2 after injury), the resolving/repair phase (day 4 after
injury) ofmuscle regeneration, and steady-state (day 0), respectively
(Fig. 1 B and Fig. S2 A). Importantly, hierarchical clustering analysis
is compatible with the notion that the sorted immune cell lineages
may be viewed and interpreted as a hierarchical continuum of cell
states (Fig. 1 B and Fig. S2 B), starting with infiltrating circulating
monocytes, and ending with repair-type MFs. The comparison be-
tween circulating monocytes and Ly6Chigh and Ly6Clow MF subsets
at each time point yielded robust changes (Fig. 1, C and D). More
specifically, volcano plots of gene expression changes between MF
subsets indicate thatmost of the transcriptional changes occurred (1)
between day 0 and day 1 (Fig. 1 C), which corresponds to the mat-
uration from circulating monocytes to Ly6Chigh infiltrating inflam-
matory MFs, and (2) between day 1 and day 4 transition from
Ly6Chigh inflammatory to Ly6Clow repair MFs (Fig. 1 D; 4,593 and
3,600 differentially expressed [DE] protein-coding genes, respec-
tively), further underscoring that these are the major transitions in
the hierarchical continuum of phenotypes (corrected P value < 0.05
and fold change [FC] ≥ 1.5; Table S1). A series of inflammatory
molecules (i.e., Spp1, Ptgs2, Il10), or ones associated with promoting
myogenesis, such as Igf1, are among the top DE genes and show
increased expression as regeneration proceeds (Table S1; Bondesen
et al., 2004; Uaesoontrachoon et al., 2013; Tonkin et al., 2015; Capote
et al., 2016). However, our analysis in Fig. 1 is primarily focused on
showing the magnitude and the quantitative and dynamic features
of gene expression changes taking place in an unbiased manner,
agnostic of gene function. These data (1) confirm that circulating
monocytes and inflammatory Ly6Chigh and repair Ly6Clow MFs are
clearly different myeloid subsets (validating previous studies using
microarrays; Varga et al., 2016b); (2) they represent the extremes of
a full spectrum ofMF activation states; and (3) they underwent large
transcriptomic changes during the time course of sterile physiolog-
ical inflammation, and particularly during the phenotypic transitions
at days 1 and 4 after injury (Fig. 1, C and D).
Transient and steadily changing transcriptional programs in
regenerative inflammation
Next, we sought to identify broad patterns and transitions
among the transcriptional changes using clustering. Protein-
coding genes were subjected to k-means clustering algorithm
based on their centered and scaled average expression values
(Fig. 1 E), using calculated optimal cluster number (k = 7) via gap
statistics (Fig. S2 C). Heatmap (Fig. 1 F) and line plots (Fig. 1 E, G,
and H; and Fig. S2 D) show the dynamically changing tran-
scriptomic profile of immune cell subsets after CTX injury, and
Table S2 provides the gene lists and membership score for each
cluster (representative examples are shown in Fig. 1 F). Among
the seven clusters, we can distinguish transcriptional programs
with transient (clusters 1, 3, 4, 6, and 7) or steadily changing
(clusters 2 and 5) dynamics (Fig. 1, E and F). Clusters 1 (red) and 7
(brown) contain 1,250 and 870 protein-coding genes, respec-
tively, which are expressed primarily at the steady-state in
circulating monocytes and correspond to transient transcrip-
tional programs that are down-regulated during the early in-
flammatory phase while they return to baseline during the
repair phase (Fig. 1, E and F; and Fig. S2 D). In a reverse fashion,
clusters 3 (green) and 6 (black) are composed of 929 and 607
genes, respectively, and correspond primarily to the acute in-
flammation phase. These clusters present a transient expression
pattern with the genes being up-regulated during this phase
while later (by day 4) they return to baseline (Fig. 1, E and F; and
Fig. S2 D). Similarly, cluster 4 (purple) contains 901 genes that
are up-regulated during the early inflammatory phase but then
remain unchanged between the muscle-infiltrating subsets
through day 4 (Fig. 1, E and F; and Fig. S2 D). Although every
cluster identified here represents an opportunity to study the
inflammation and regeneration dynamics ofMF gene expression
(as evidenced by the coexpression modules on Fig. S2 E), we
found intriguing the existence of continuous/nontransient
changes. Thus, we decided to focus on clusters 2 and 5 (con-
taining 716 and 952 protein-coding genes, respectively) with a
steadily increasing or decreasing gene expression pattern (Fig. 1,
G and H). We hypothesized that genes in these two clusters
contribute in a deterministic way to establish the repair MF
lineage identity and can reveal the sensory and regulatory events
associated with this cellular phenotype. In fact, our systematic gene
set enrichment analysis (GSEA) found that several known regulators
and effectors of MF activation/maturation (i.e., Adgre1, Aif1, Stat6,
either blood or injured TA muscles, FACS-sorted at indicated time points after CTX injury (gating strategy is shown in Fig. S1, A–D), and subjected to RNA-seq
(n = 3 or 4 samples per population), followed by downstream analyses. (B) Multidimensional scaling plot on normalized mRNA expression values of blood
monocytes, Ly6Chigh, and Ly6Clow muscle-infiltrating MFs reflecting the overall relationship between datasets. Arrows indicates the developmental trajectory
during the injury and regeneration time course. (C) Differential gene expression (assessed by RNA-seq) between sorted inflammatory day 1 Ly6Chigh MFs versus
blood monocytes (n = 3 biological replicates per group). Gating strategy for the MF subsets isolation is shown in Fig. S1, A and B. A volcano plot (log2 FC versus
negative log of P value) was used to visualize statistically significant gene expression changes (fold ≥1.5 and adjusted P value <0.05). Statistically significant
difference was considered FDR <0.05 from GLM test. Representative top regulated genes are labeled. The number of DE genes is indicated in the upper left
corner. (D) Differential gene expression (assessed by RNA-seq) between reparatory day 4 Ly6Clow versus inflammatory day 1 Ly6Chigh sorted MF populations
(n = 3 or 4 biological replicates per group). Gating strategy for the MF subsets isolation is shown in Fig. S1, B and D. A volcano plot (log2 FC versus negative log
of P value) was used to visualize statistically significant gene expression changes (fold ≥1.5 and adjusted P value <0.05). Statistically significant difference was
considered FDR <0.05 from GLM test. Representative top regulated genes are labeled. The number of DE genes is indicated in the upper left corner. (E) Line
plot showing the dynamics of gene expression and cluster centroids identified by k-means in sorted blood monocytes and muscle-infiltrating MFs after CTX
injury. (F) Heatmap representation of seven defined clusters with differential gene expression (scaled expression; row Z-score) dynamics in blood monocytes
and muscle-infiltrating MF populations. Area plots (left) show the overall gene expression dynamics of the clusters (visualized in relation to cluster centroids).
The heatmap illustrates all the genes per cluster with representative genes (with high membership scores) for each cluster shown on the right side. Highlighted
in red are the genes that translate to secreted proteins as defined in the VerSeDa. (G and H) Line plots showing the dynamics of all genes (expression Z-score)
within clusters 2 (G) and 5 (H). Centroids are represented with black lines. Color density shows the correlation of a given gene with its centroid. The number of
genes within each cluster is shown in the bottom right corner. D, day.
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Rara, Sell) and repair function (i.e., Igf1, Gdf3; Fig. 1 F) belong
to these two clusters, and may play key roles in shaping re-
pair MF identity. Functional classification with gene ontol-
ogy (GO) analysis (REACTOME pathways database) revealed
categories belonging to MF activation, function, metabolism,
and immune system regulation (Fig. S2, F and G). Specifically
in cluster 2, we observed an enrichment in pathways such as
those associated with IL signaling (i.e., Stat5a, Il17ra, Csf2ra,
Il31ra1, Il6ra, Stat6), NF-κB activity–regulating pathways
(i.e., Nfkb1, Myd88, Irak3, Map3k6), regulation of necroptotic
cell death and macroautophagy (i.e., Atg9a, Atg4c, Mlst8,
Prkab2, Tomm5), and platelet homeostasis (i.e., Pecam1, Itpr1,
Fgr; Fig. S2 F). In cluster 5, we observed an enrichment in
innate immune activation (i.e., C1qa, C1qc, Cd4, Cd81, Ctsa,
Itgax, Tlr8, Tlr1, Tlr3, Tlr12, Trem2, Fcgr4), neutrophil de-
granulation (i.e., Folr2, Sirpa, Psap, Alad), lipid, carbohy-
drate, and vitamin metabolism (i.e., Mdh1, Lyve1, Slc25a10,
Tkfc, Ndst1, Galns, Cspg4, Bgn, Apoe, Lpl, Vkorc1, Hexa, Ltc4s,
Hpgds), collagen biosynthesis (i.e., Col1a2, Col11a2, Col15a1,
Col1a1, Col3a1, P3h1, Colgalt1, Crtap), iron metabolism
(i.e., Slc40a1, Hmox2, Slc46a1, Atp6v0d2), and cell cycle phase
transition (i.e.,Mcm4, Cdk1, Pola1; Fig. S2 G). Thus, focusing on
the top DE genes that follow cluster’s 2 and 5 kinetics could
reveal novel regulators and effectors that establish and
maintain the repair/resolution phases of the MF-mediated
regeneration process in a continuous fashion without neces-
sarily being involved in the early inflammatory phase of the
process.
In addition, the genes sharing the same expression kinetics in
clusters 2 and 5 may be regulated by the same or similar regu-
lators, in particular transcription factors (TFs). Thus, in a com-
plementary analysis and to further illuminate the biological
activities represented in clusters 2 and 5, we used the Ingenuity
Pathway Analysis (IPA) Upstream Regulator Analysis to identify
the cascade of potential upstream transcriptional regulators
that could explain the observed gene expression kinetics. This
analysis examines how many known targets of each transcrip-
tion regulator are present in our clusters. We identified 86
upstream transcriptional regulators with at least 15 known
regulated target molecules in cluster 5, including several ligand-
dependent nuclear receptors such as PPARα/δ, NR1H3, AR, RXRa,
AHR, ESR1, NR3C1, and PPARγ (Fig. S3 A, underlined) and other
transcriptional regulators involved in proliferation/cell cycle (TP53,
HNF4a, NUPR1, TBX2, CDKN2A, E2F4), and inflammation/MF mat-
uration (AP-1 factors, CEBPB,MAFB,NFE2L2, STAT6, RB1, SMARCB1,
TCL1A, E2F1, MITF, YY1, HDAC1, and KDM5; Fig. S3 A). Similarly, in
cluster 2, we identified 65 upstream transcriptional regulators, some
observed in the previous analysis, such as TP53, HNF4a, STAT family
members, and others such as IFN regulatory factor (IRF) and
Krüppel-like factor familymembers, FOXO3, RUNX1, GATA1, and SP1
(Fig. S3 B). Next, we prioritized and grouped the identified genes for
further analyses, focusing on potential new effectors.
Identification of GDF-15 as a prototypic and novel secreted
effector in Ly6Clow repair MFs
The complete longitudinal time course analysis allowed us to
identify the unexpected, steadily changing clusters of genes (C2
and C5) and an enrichment of secreted growth regulating factors
in the latter (Fig. 1 F). Next, we decided to follow up this lead and
carry out a direct comparison of repair Ly6Clow cells to circu-
lating monocytes, which is its precursor. We argued that this
analysis can provide insights into how nontransient lineage
transcriptional programs establish the repair MF subset from a
naive monocytic state (Fig. 2 A). The up-regulated genes in this
comparison (Table S1) were associated with protein secretion,
the regulation of endothelial cell proliferation, and GO categories
related the late steps of regeneration such as response to growth
factors, wounding, tissue remodeling, endocytosis, autophagy,
leukocyte differentiation, inflammation (IL-6, TNF, and regula-
tion of TGF-β pathways), and negative regulation of leukocyte
migration, adhesion, and apoptosis (Fig. S3 C). This analysis also
showed down-regulation of genes associated with early stages of
regeneration, such as leukocyte migration, adhesion, cell mo-
tility, necrotic cell death, and intracellular signal transduction
associated with immune responses and cell communication
(regulation of cytokine production; response to IL-2, and IFN-γ;
Fig. S3 D). Interestingly, the top genes that were up-regulated at
day 4 in the Ly6ClowF4/80high MFs versus blood monocytes
comparison are known inflammation/repair secreted effector
molecules (i.e., Igf1, Gdf15, Spp1, Gpnmb; Uaesoontrachoon et al.,
2013; Tonkin et al., 2015; Capote et al., 2016; Silva et al., 2018)
and scavenger receptors (i.e., Stab1, Fcrls; Fig. 2 A; Palani et al.,
2011; Rantakari et al., 2016). This observation is entirely con-
sistent with the role of Ly6Clow repairMFs in the initiation of the
resolution and repair phase of the inflammatory response fol-
lowing injury. To prioritize this extensive DE gene list (3,966
genes, FC ≥ 1.5) and identify new pathways that could impact MF
identity, we overlapped it with the genes identified previously in
clusters 2 and 5. We found 766 genes from cluster 5 (80.5%
overlap) and 594 genes from cluster 2 (83% overlap) belonging to
this DE gene list (Fig. S3 E), validating the approach. Next, we
filtered this list based on high levels of expression in either the
blood monocytes (represented by cluster 2) or Ly6Clow repair
MFs of day 4 (represented by cluster 5). The top 50 genes
passing our criteria were manually curated and grouped into
functional categories (Fig. 2 B). Among these genes, we found a
series of molecules involved in the interactions with adaptive
immunity/antigen presentation (Cd74, H2-Aa, H2-Ab1, H2-Eb1,
Snx5), anti-inflammatory/regulatory factors (Apoe, Sepp1, Grn,
Pltp, Trem2, Lipa, Cxcl16, Acp5, Chil3, Chil4, Gpnmb), secreted
growth factors (Igf1, Gdf15), effectors and enzymes involved in
iron (Slc40a1) and lipid/cholesterol (Pla2g15, Abcg1, Hpgds)
homeostasis, lysosomal proteases (Tpp1), DNA methylation
(Dnmt3a), exonucleases (Pld3), extracellular matrix remodeling
(Timp2, Ctsb), as well as receptors involved in TGF-β signaling
(Tgfbr2, Tgfbr1), scavenging (Fcrls), efferocytosis (Gas6, C1qc,
C1qa, C1qb), and importantly MF maturation/tissue resident
markers (Adgre1,Ms4a7, Siglec1, Itgax, Aif1,Mertk, Folr2). We also
observed a substantial decrease in the expression of genes in-
volved in cell adhesion (Sell, Cd177, Itgb7), acute phase/pro-in-
flammatory responses (Gsr, Ace, Ifitm6, Hp), and monocyte
identity markers (Ccr2, Ly6c2, Ly6c1, Serpinb10, Plac8), as ex-
pected (Fig. 2 B). Using the UniProtKB and Vertebrate Secre-
tome Database (VerSeDa)mouse protein databases (we considered
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Figure 2. Identification of GDF-15 as a novel effector in muscle-infiltratingMFs during regeneration. (A) Differential gene expression (assessed by RNA-
seq) between repair day 4 Ly6Clow MFs versus blood monocytes. A volcano plot (log2 FC versus negative log of P value) was used to visualize statistically
Patsalos et al. Journal of Experimental Medicine 6 of 30
Macrophage-derived GDF-15 in muscle regeneration https://doi.org/10.1084/jem.20210420
records with information extracted from literature and curator-
evaluated computational analysis), we could further curate 19 of
these genes into molecules with reported secreted effector func-
tion like Gdf15, Igf1, Siglec1, Gas6, C1qc, C1qa, C1qb, Pla2g15, Timp2,
Ctsb, Apoe, Sepp1, Grn, Pltp, Trem2, Chil3, Chil4, Ace, andHp (Fig. 2 B,
highlighted in red).
A well-established effector in the context of MF-mediated
muscle repair is IGF-1. IGF-1 is a growth factor secreted by re-
pair MFs and is a potent enhancer of tissue regeneration (Lu et al.,
2011). It is involved in the activation, proliferation, and differen-
tiation of satellite cells (Hill and Goldspink, 2003; Mourkioti and
Rosenthal, 2005), but can also act as a key factor in the resolution
of inflammation and the inflammatory to repair MF phenotype
switch during muscle injury and regeneration (Tonkin et al.,
2015). To date, this is the only secreted factor with a bivalent
role in sterile inflammation and tissue repair, by acting in both a
paracrine and an autocrine manner. Thus, in an independent
analysis and to identify targets with a similarly strong predictive
power for repair Ly6Clow MF functionality, we performed a
Pearson similarity metric analysis to find genes that follow similar
expression trend and rate to Igf1, through the entire course of
regeneration (similarity cutoff set at ≥0.9). Altogether, 918 genes
were identified (Fig. 2 C), among which were 26 genes from the
above top-ranked gene list (Fig. 2 B), which is essentially the
molecular signature of Ly6Clow repair MFs. At the top of these
lists, the only other secreted growth factor was Gdf15 (Fig. 2 D);
that is also amember of the TGF-β superfamily like IGF-1 (Bootcov
et al., 1997; Lawton et al., 1997), with Pearson similarity of 0.937
(Fig. 2 C) and almost identical expression levels and kinetics to Igf1
(Fig. 2, B and E). At the protein level, GDF-15 becomes detectable at
day 3 after CTX injury and peaks at day 4 in whole-muscle lysates
(Fig. 2 F), both as a propeptide and as a mature monomer
(Fig. 2 G). The protein expression closely followed the induction
seen at the mRNA level in MFs of day 4 (Fig. 2 D), at a time when
inflammation subsides, and regenerative processes start to dom-
inate within the injured muscle. Notably, the induction of GDF-15
expression was detectable only in the CD45+ (hematopoietic)
compartment, suggesting that CD45+ cells are the sole local source
of active GDF-15 during the regeneration process (Fig. 2 H). It is
also important to note that the GDF-15 protein induction during
CTX injury was undetectable in muscle samples from Gdf15 KO
animals (Fig. 2 G), validating our detection method and reagents.
Based on these findings, GDF-15’s role in MF-mediated regenera-
tion warranted further investigation. We hypothesized that GDF-
15 could be a novel repair MF–derived factor acting similarly to
IGF-1 by influencing the outcome of skeletal muscle regeneration
either as a regulator of repair MF function and/or as an effector/
growth factor acting on the muscle tissue itself.
GDF-15 is required for proper muscle regeneration
To assess the role of GDF-15 during muscle regeneration, we used the
CTX injury model and used an established genetic GDF-15 ablation
model (Hsiao et al., 2000). In this model, muscle regeneration was
severely impaired at day 8 after CTX, in comparison to control mus-
cles as shown by histological analysis (Fig. 3 A, top). Morphometric
analysis validates this impairment, as illustrated by a shift to the left
(toward small fiber sizes) of the distribution of the myofiber cross-
sectional area (CSA; Fig. 3 A, bottom), a 19% decrease in themeanCSA
of regenerating myofibers (Fig. 3 A, inset), and a decrease in myosin
heavy chain 2 (Myh2) expression (Fig. 3 C), all indicative of an im-
pairment in regenerating myocyte organization and fiber content.
Next, we wanted to determine whether regeneration was still im-
paired at later stages of the process in the Gdf15 KO. Intriguingly, both
at day 12 and day 16 after CTX, theGdf15KO failed to recover to control
levels, as illustrated by histological analysis (Fig. 3 B), a shift to the left
of the distribution of themyofiber CSA (Fig. S4, A and B), and a 13.3%
or 10.8% decrease in the mean CSA of regenerating myofibers at day
12 and day 16, respectively (Fig. S4, A and B, insets). Although no
significant difference in the CSA was observed at day 21 after injury
(Fig. S4 C), we did observe a significant increase in ectopic lipid ac-
cumulation (Fig. 3, B andD) and cell infiltration (Fig. S4 D), both being
hallmarks of defectivemuscle regeneration. It is important tonote that
no preexisting developmental musculature impairment was observed
in myeloid or full-body Gdf15 KO uninjured muscles (day 0), as as-
sessed byhistological analysis (Fig. S4 E), fiber CSAmeasurement (Fig.
S4 F), hindlimb grip strength (Fig. S4 G), and in vivo force measure-
ments (Fig. S4, H and I), suggesting that GDF-15 is not required for
embryonic muscular development and that the muscle regeneration/
growth impairment is only evident after an acute injury.
Myeloid GDF-15 impacts both infiltration and phenotypic
transition of MFs following CTX injury
To exclude the involvement of confounding or compensatory
mechanisms in other tissue compartments and to determine
significant gene expression changes (fold ≥1.5 and adjusted P value <0.05). Representative top regulated genes are labeled in black. Highlighted in purple labels
are known scavenger receptors and inflammation/repair-related genes. The number of DE genes is indicated in the upper left corner. (B) Heatmap showing the
mRNA expression pattern of the top 50 genes passing a set of criteria (1) being DE in the analysis in A, (2) included in cluster 2 or 5, and (3) high expression (in
CPM reads mapped) in blood monocytes, Ly6Chigh, or Ly6Clow muscle-infiltrating MFs. RNA-seq expression values are visualized as normalized expression (log2
[CPM]), and each gene shown is clustered into functional categories. Highlighted in red are the genes that translate to secreted proteins defined in the
VerSeDa. (C) Dot plot showing genes with similar trend and rate to Igf1 (Pearson similarity 0.9–1.0). Labeled genes have Pearson similarity >0.93 and high
normalized expression (log2[CPM] >7.5] in day 4 Ly6Clow repair MFs. Igf1 and Gdf15 are highlighted in red and blue, respectively, and green dotted lines indicate
the labeling cutoffs. (D) Genome browser view of the Gdf15 locus from blood monocytes, Ly6Chigh, and Ly6Clow muscle-derived MFs RNA-seq datasets. (E) Line
plot illustrating the gene expression dynamics of all genes (row Z-score) within cluster 5 in blood monocytes, Ly6Chigh, and Ly6Clow muscle infiltrating MFs. The
expression dynamics of Gdf15 and Igf1 are highlighted with blue and red, respectively. (F) GDF-15 protein expression in whole-muscle lysates of regenerating TA
muscles from WT male mice at indicated time points. Three biological replicates are quantified for each time point with normalized values to total protein of
each sample (n = 3 per time point). REVERT total protein was used for loading control and signal normalization. (G) GDF-15 protein expression (in propeptide
and monomer form) in whole-muscle lysates of regenerating muscles from WT and Gdf15 KO mice at day 4 after CTX. Top: An illustration of GDF-15 peptide
structure. REVERT total protein was used for loading control and signal normalization. (H) GDF-15 protein expression in CD45+ and CD45− cells isolated at
indicated time points after CTX injury from WT mice (n = 3 per time point). REVERT total protein was used for loading control and signal normalization.
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Figure 3. GDF-15 deficiency leads to impaired muscle regeneration and impacts the MF phenotype switch. (A) Top: Representative images of H&E-
stained skeletal muscle (TA) from WT-control and Gdf15 KO animals at day 8 after CTX-induced injury. Scale bars in the upper left corner represent 100 µm.
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whether GDF-15 deficiency in the hematopoietic/myeloid com-
partment is the major contributor to the observed delayed re-
generation phenotype, we generated chimeric animals reconstituted
with Gdf15 KO bone marrow (BM). In this model, BM from Gdf15
KO or control mice was used to reconstitute the hematopoietic
compartment of total body–irradiated WT-control animals.
Compared with animals that received WT BM, GDF-15–deficient
BM chimeras exhibited a profound impairment in regeneration
at day 8 after injury (Fig. 3 E), similar to the full-body Gdf15 KO
(Fig. 3 A). When compared with WT BM-transplanted (BMT)
animals, Gdf15 KO chimeras contained more regenerating my-
ofibers with smaller CSA as illustrated by a shift to the left (to-
ward small fiber sizes) of the distribution of the myofiber CSA
(Fig. 3 E, bottom), and a 24.5% decrease in the mean CSA of re-
generating myofibers (Fig. 3 E, inset). Altogether, the results
from the two distinct loss-of-function genetic models and the
high expression of GDF-15 in the repair Ly6Clow MF compart-
ment of the hematopoietic niche indicated that myeloid-derived
GDF-15 critically contributes to muscle regeneration.
Next, we asked whether the impaired muscle regeneration
was caused by a defect in the cellular dynamics of the myeloid
cell infiltrate during muscle regeneration. The regenerative
areas contained increased inflammatory infiltrations (F4/80+
cells) in Gdf15 KO muscles at day 8, as assessed by immunohis-
tochemistry (Fig. S4, J and K), and were independent of local
proliferation (Fig. S4 L), suggesting that the infiltration and
resolution of inflammation were impaired. Interestingly, we also
observed differences in the numbers of invading myeloid cells
(CD45+) at day 4 after CTX injury using CD45+ magnetic bead
selection (Fig. 3 F), which is in line with GDF-15’s role in regu-
lating immune cell infiltration (Kempf et al., 2011). However,
this finding did not exclude the possibility of a change in the
cellular composition and subtype specification of the infiltrating
myeloid cells as well. Since Gdf15 is expressed highly in repair
MFs, we decided to follow the differentiation dynamics of MFs at
day 4, as the observed effect of GDF-15 deficiency must derive
from these MFs subsets. Therefore, we examined the dynamics
of the infiltrating myeloid cell populations (inflammatory Ly6-
Chigh F4/80low and repair Ly6Clow F4/80high MFs) during the
regeneration phase by flow cytometry (Fig. 3, G and H). Ly6Chigh
inflammatoryMFs are progressively differentiating into Ly6Clow
repair MFs by day 4 after CTX injury (Fig. S1, B–D). In the case of
the Gdf15 KO, the frequencies of both inflammatory Ly6Chigh F4/
80low and Ly6Clow F4/80high repair MFs were skewed compared
with controls (Fig. 3, G and H, top), suggesting a decreased
conversion of inflammatory to repair MFs. Although the ob-
served alteration in the proportion of MFs was significant, it
must be noted that the ratio and absolute numbers (Fig. 3 I and
Fig. S4 S) of infiltrating neutrophils (Ly6G+ F4/80−Ly6Cint) were
also significantly higher in the absence of GDF-15, further sug-
gesting that the proper clearance of neutrophils and the overall
resolution of inflammation was altered. Concurrently, the re-
cruitment of dendritic cells (DCs; Fig. S4, M–O) and natural
killer (NK) cells (Fig. S4, P–R) is reduced at day 4 after CTX in the
Gdf15 KO. These findings indicate that the dynamics of immune
cell recruitment are significantly impacted in the Gdf15 KO.
Assessing more functional markers, such as the MHCII
molecules, which were incorporated recently as an alternative
gating strategy for muscle-infiltrating MFs (Panduro et al.,
2018), we observed a decrease in the ratio of MHCII+ F4/80high
cells at day 4 (Fig. 3, J and H, bottom), suggesting a potential
impairment in the antigen-presenting capacity of these cells.
Collectively, these results show that GDF-15 deficiency has
quantitatively and qualitatively affected myeloid cells’ infiltra-
tion and in situ differentiation and reveal a critical role for
myeloid-secreted GDF-15 as a potent effector and coordinator of
the resolution of inflammation in regenerating muscle.
MF-secreted GDF-15 regulates myoblast proliferation and
influences MF antigen-presenting capacity
As only a few paracrine signaling pathways between MFs and
tissue progenitors have been described thus far, we decided to
identify the possible effector functions of GDF-15 that might
connect muscle-infiltrating repair MFs to the regenerating cell
milieu in a paracrine manner. A possible cell target interaction
in the regenerating muscle microenvironment is, of course, the
muscle progenitor cells. To determine if satellite cells are af-
fected in the absence of GDF-15, we first quantified the number
Bottom: Fiber size repartition of regenerating muscle in WT-control and Gdf15 KO animals at day 8 after CTX injury (two-way ANOVA with multiple comparison
test). Inset shows the average fiber CSA of regenerating muscle at day 8 after CTX injury (n = at least 4 mice per group). (B) Representative images of H&E-
stained skeletal muscle (TA) fromWT-control and Gdf15 KO animals at days 12, 16, and 21 after CTX-induced injury. Scale bars in the upper left corner represent
100 µm. (C) Myh2mRNA expression in WT-control and Gdf15 KOmuscles at day 8 after CTX injury (n = 6 muscles per group). Myh2 was normalized over Rpl32
(n = 3 independent experiments). (D) Percentage of ectopic lipid deposition relative to the muscle regeneration area at day 21 of regeneration in WT-control
and Gdf15 KO muscles is shown (n = 8 mice per group). (E) Top: Representative images of H&E-stained TA skeletal muscle 8 d after CTX injury from chimeric
WT BoyJ BMT animals (CD45.1 recipients) that received either WT (CD45.2) or Gdf15 KO BM. Scale bars in the upper left corner represent 100 µm. Bottom:
Cumulated myofiber CSA repartition (two-way ANOVAwith multiple comparison test) and mean CSA (inset) at day 8 after CTX injury from BMT animals (n = at
least 8 mice per group, two-way ANOVA). (F)Number of infiltrating myeloid (CD45+) cells in regeneratingmuscle fromWT-control and Gdf15 KOmuscles at day
4 after CTX injury (n = 4 mice per group). (G) Frequency (in %) of CD45+ inflammatory (Ly6Chigh F4/80low) and repair (Ly6Clow F4/80high) MFs fromWT-control
and Gdf15 KO mice at day 4 following CTX injury (n = 6 mice per group). (H) Representative flow cytometry 10% quantile contour plots of inflammatory and
repair MFs from WT-control and Gdf15 KO at day 4 after CTX injury. Shapes indicate the gating used for cell frequency quantification (square = Ly6Chigh
inflammatory MFs, circle = Ly6Clow repair MFs, rectangle = MHCII+ MFs). Representative frequencies for each cell population are shown adjacent on inside each
gate. x and y axis numbers indicate the fluorescence intensity (on the log10 scale) of the indicated fluorescent-labeled antibodies for all the plotted events. PB,
Pacific Blue; APC, allophycocyanin. (I) Number of infiltrating neutrophils (CD45+ Ly6G+ Ly6Cint F4/80−) cells in regenerating muscle fromWT-control and Gdf15
KO muscles at day 4 after CTX injury (n = 4 mice per group). (J) Frequency (in %) of CD45+ F4/80+ MHCII+ MFs from WT-control and Gdf15 KO mice at day 4
following CTX injury (n = 10 mice per group). In all bar graphs, bars represent mean ± SEM. Exact P values were determined using unpaired Student’s t test
unless otherwise noted. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001. PE, phycoerythrin.
Patsalos et al. Journal of Experimental Medicine 9 of 30
Macrophage-derived GDF-15 in muscle regeneration https://doi.org/10.1084/jem.20210420
of PAX7+ cells in uninjured muscles of adult control and Gdf15 KO
animals through immunohistochemistry (Fig. 4 A). We didn’t de-
tect any significant a priori differences in the numbers of satellite
cells at this stage. Next, we measured the mRNA expression of a
commonly used marker, Pax7 (von Maltzahn et al., 2013), via
quantitative PCR (qPCR) and quantified the number of PAX7+ cells
in regenerating Gdf15 KO muscles at day 4 after CTX injury. Our
data show that Pax7 mRNA expression is decreased in Gdf15 KO
muscles compared with controls at day 4 after injury (Fig. 4 B). In
agreement with these results, PAX7 staining revealed fewer PAX7+
cells in theGdf15 KOmuscles at the same time point (Fig. 4 C). These
results suggest that the expansion of PAX7+ satellite cells upon
injury is sensitive to GDF-15 signaling interactions and is likely to
be one of the major causes of the muscle regeneration deficiency
observed in the Gdf15 KO animals. Thus, we hypothesize that GDF-
15 may act on satellite cells by affecting their proliferation and
differentiation. To assess the effect of GDF-15 on proliferation and
fusion, cultured primarymyoblasts were treatedwith recombinant
GDF-15 at various doses (Fig. 4, D–G). Using Ki67+ staining as a
positive indicator of proliferation, or desmin for myotube forma-
tion, the addition of 500–750 ng of recombinant (r) GDF-15 to the
culture increased myoblast proliferation (Fig. 4, D and E) but had
no effect on their differentiation (Fig. 4, F and G), suggesting a
regulatory role in activating satellite cell proliferation pathways.
MF-secreted GDF-15 can also have direct effects on the myeloid
cell compartment. To assess the potential autocrine function of
GDF-15 on the inflammatory component of the regeneratingmuscle,
we injected intramuscularly a single dose of recombinant GDF-15
(30 µg/kg) into CTX-injured muscles of WT mice on day 1 or 3 and
accessed the myeloid cell composition at day 2 and 4 after CTX by
FACS, respectively. We found that the exogenously added GDF-15
decreased the total number of infiltrating CD45+ cells at day 2 after
injury (Fig. 4 H), in line with previous observations (Kempf et al.,
2011; Zhang et al., 2017), skewed MFs toward expressing higher
levels ofMHCIImolecules both at day 2 and day 4 after CTX (Fig. 4, I
and J), and increased the ratio of Ly6Clow/Ly6Chigh MFs at day 4
(Fig. 4 K). These data suggest that GDF-15 promotes an accelerated
phenotypic transition and can have a positive effect on the matu-
ration and antigen-presenting capacity of these MFs. Last, admin-
istration of a single dose of exogenous GDF-15 (administered at day
4 after CTX) in WT mice had a modest but not statistically signifi-
cant regeneration-enhancing effect in vivo (Fig. 4 L). This finding
suggests that (1) the endogenous physiological levels of GDF-15 are
sufficient for proper regeneration, and (2) regeneration must be
impaired for the rGDF-15 treatment to have any effect. These
findings are in line with a previous study on the beneficial role of
rGDF-3 in regeneration, where only aged animals with impaired
regeneration, but not young animals, benefited from the addition of
this growth factor (Patsalos et al., 2018).
Overall, GDF-15 appears to be an effector in regeneration
with bivalent and pleiotropic roles in skeletal muscle inflam-
mation/resolution and regeneration.
GDF-15 is a bona fide transcriptional target of liganded PPARγ
and RXR in MFs
Next, we decided to pursue the identification of the putative
regulatory circuit upstream of Gdf15. We have recently described
the chromatin accessibility landscape in muscle-infiltrating MFs
(Patsalos et al., 2019). We used these Assay for Transposase-
Accessible Chromatin using sequencing (ATAC-seq) datasets to
gain insights into the regulation of Gdf15 in muscle-infiltrating
MFs. Initially, we analyzed the cistrome around the Gdf15 locus
with the goal to identify distal differentially accessible chro-
matin regions, which could act as potential enhancers, and then
try to predict in silico bindingmotifs at these sites.We identified
two sites located ∼2.6 kb (proximal, E1) and ∼3.6 kb (distal, E2)
upstream of the Gdf15 transcription start site that are changing
during the course of regeneration in the muscle-infiltrating
MFs. These putative enhancer regions show both differential
chromatin accessibility (Fig. 5 A), in line with the gene ex-
pression data (Fig. 2 D), and strong DR1 (PPARG:RXRA) binding
motifs (Fig. 5 A, right). These motifs are identical, although the
distal one is located in a repetitive, lower-complexity region
with smaller chromatin openness. Nevertheless, these se-
quences contain the PPAR-specific 59 extension that provides
minor groove binding, so overall, tighter DNA–protein inter-
actions (Nagy and Nagy, 2020). In addition, based on prior
knowledge of expected effects between transcriptional regu-
lators and their target genes stored in the Ingenuity Knowledge
Base, we identified PPARγ and RXRα as likely relevant tran-
scriptional regulators of Gdf15 expression (Fig. S3 A, highlighted
in bold). Furthermore, in a previous study (Varga et al., 2016b) of
muscle-infiltrating MFs, Gdf15 showed partial PPARγ depen-
dency as it was among the DE genes in PPARγ-deficient muscle
MFs (Fig. S3 F). Based on these findings, we hypothesized that
MF PPARγ and its partner, RXRα, target Gdf15 to establish the
repair MF identity and regulate skeletal muscle regeneration.
To determine the molecular mechanisms of how PPARγ and
RXRα regulate Gdf15 expression, we performed chromatin im-
munoprecipitation sequencing (ChIP-seq) in BM-derived MFs
(BMDMs). Consistent with our ATAC-seq data, and the in silico
motif analysis, we observed that both RXRα and PPARγ binding
occur along the predicted Gdf15 enhancer regions (Fig. 5 B). In
addition, PPARγ and RXRα are nuclear receptors that can sense
and interpret fatty acid signals, and thus can be activated by
pharmacological targeting. BMDMs were treated for 1 h with
LG268 or Rosiglitazone, a potent RXRα- and PPARγ-specific
agonist, respectively, and RNA polymerase II–specific ChIP-seq
was performed to map the ligand-specific genome changes. We
observed a significant increase of RNA pol II binding in the Gdf15
coding region in response to both agonists, suggesting active
transcription (Fig. 5 B). To validate these results at the mRNA
level, we proceeded to treat cultured BMDMs with LG268, Ro-
siglitazone, AM580, and GW2965, the latter two being RARα and
LXRβ agonists, respectively, and measured Gdf15mRNA levels at
3 h after treatment by qPCR (Fig. 5 C). In response to LG268 and
Rosiglitazone, we observed a significant increase of Gdf15mRNA,
whereas treatment with AM580 and GW3965 resulted in mRNA
levels consistent with basal Gdf15 expression observed in the
nontreated control (Fig. 5 C). Furthermore, to confirm whether
the predicted enhancer regions are indeed accessible and active
upon PPARγ and RXRα ligand treatments, we measured the
enhancer RNA (eRNA) expression of these loci in untreated
versus LG268- and Rosiglitazone-treated BMDMs (Fig. 5 D). As
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Figure 4. Effects of recombinant GDF-15 onmuscle progenitor proliferation in vitro andMHCII expression ofmuscleMFs in vivo. (A)Number of PAX7+
cells in uninjured TA muscles of WT-control and Gdf15 KO (n = 14 muscles per group). (B) Quantification of Pax7 gene expression (mRNA) using qPCR in
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expected, the enhancer RNAs around the Gdf15 locus are acti-
vated by both ligand treatments (Fig. 5 D). To further expand on
these findings, we compared the Gdf15 mRNA expression be-
tween WT and RXRafl/fl LysMCre/RXRb−/− BMDMs in response
to the same ligands (Fig. 5 E). In the WT-control BMDMs, Gdf15
mRNA expression is substantially elevated in response to either
LG268 or Rosiglitazone treatment, as observed previously (Fig. 5
C), and even more so when treated in tandem (Fig. 5, E and F). In
contrast, Gdf15 mRNA expression in RXRafl/fl LysMCre/RXRb−/−
BMDMs shows no response to either LG268 or Rosiglitazone
treatment (Fig. 5 E). In parallel, Gdf15 was among the 132 genes
that belong to cluster 5 and show RXR dependency (down-reg-
ulated) in RNA-seq data from unstimulated RXR-deficient
BMDMs (Fig. S3 G). Interestingly, in comparison with a re-
cently discoveredmyogenic factor (Varga et al., 2016b) with high
similarity to GDF-15, namely GDF-3 (it belongs to the same su-
perfamily of growth factors as GDF-15), and the discovery of
ligand-independent gene regulation by PPARγ (Daniel et al.,
2018), we were interested to explore if these two factors are
regulated and behave in a similar fashion. Gdf3 is expressed and
secreted by repair MFs under the control of PPARγ but does not
respond to either PPARγ or RXRα ligand treatments (Fig. 5 F), in
contrast with Gdf15, which responds to both. This ligand-
independent regulation of Gdf3 suggests that both these
growth factors may be regulated by the same TFs at the same
point in time but with different modes of action (ligand-sen-
sitive versus ligand-insensitive). Taken together, these
findings suggest that the Gdf15 locus has multiple PPARγ:RXR
heterodimer-bound active enhancers and that liganded PPARγ
and RXR are direct regulators of Gdf15 expression in MFs and
subsequently propose their involvement in the muscle regen-
eration process.
Skeletal muscle regeneration is impaired in RXRα/β myeloid-
deficient animals
While some aspects of PPARγ’s role in muscle regeneration have
been previously demonstrated (Varga et al., 2016b), the role of
MF RXR in skeletal muscle injury and regeneration is not
known. We hypothesized that MF RXR is a regulator of skeletal
muscle regeneration, in part by controlling GDF-15’s expression
in repair MFs. This model posits that RXR deficiency in MFs
should yield impairment in regeneration. However, the extent
and direction of the impairment cannot be predicted given the
pleiotropic nature of the role of a TF. To test this hypothesis, we
used the double knockout RXRafl/fl LysMCre/RXRb−/− mouse
strain, which is deficient in Rxrα specifically in myeloid lineages
and Rxrb in all cell types (Kiss et al., 2017). Histological analysis
reveals impaired regeneration at day 8 after CTX injury in
RXRafl/fl LysMCre/RXRb−/− animals versus controls (Fig. 6 A). In
addition, at this time point, we observe a significant increase in
necrotic fiber content (Fig. 6 B) and a 22% reduction in mean
fiber CSA in RXRafl/fl LysMCre/RXRb−/− versus control muscles
(Fig. 6 C), indicating either a delayed clearance of dying my-
ofibers or altered dynamics of muscle fiber death in the KO
animals. Interestingly, this delay in regeneration is still evident
at day 21 after injury (Fig. 6 D), as evident by the significant
reduction in mean fiber CSA (Fig. 6 E) and muscle mass
(Fig. 6 F). At the same time, no developmental impairment was
observed in RXRafl/fl LysMCre/RXRb−/− uninjured muscles
(Fig. 6, G and H), suggesting that the muscle regeneration im-
pairment phenotype in this mouse strain is evident only after
injury.
Based on our prior Gdf15 expression data in BMDMs, we
hypothesized that Gdf15 could be one of the genes dysregulated
in the RXRα/β null muscle-MFs. Thus, to assess the impact of
RXRα/β deficiency and validate the regulation of Gdf15 by RXR,
specifically in the day 4 repair muscle-MFs, we quantified the
Gdf15mRNA in FACS-sorted Ly6Clow MFs (Fig. 6 I). We observed
a significant reduction in Gdf15 mRNA levels in this day 4 MF
subpopulation, which is in accordance with the reduction of
GDF-15 protein levels in either RXRα/β or PPARγMF-specific
KO whole muscle lysates (Fig. 6 J). These results prompted us
to ask whether the MF infiltration and cellular dynamics
have been altered in the RXRα/β double knockout animals
upon CTX injury. Indeed, quantification of CD45+ cells at day
4 after CTX injury reveals a pronounced increase in the ac-
cumulation of myeloid cells in the RXRafl/fl LysMCre/RXRb−/−
animals (Fig. 6 K). However, analyzing the fractions of MF
WT-control and Gdf15 KOmuscles at day 4 after CTX injury (n = 6 or 7 biological replicates per group). Pax7was normalized over Rpl32. (C) Left: Representative
images of IHC detection of laminin (red), PAX7 (green), and nuclei (blue) inWT-control and Gdf15 KO at day 4 after CTX injury. Scale bars in the upper left corner
represent 100 µm. Right: Number of PAX7+ cells inWT-control and Gdf15 KO at day 4 after CTX injury (n = 12 muscles per group). (D) Ki67 (red) and DAPI (blue)
immunofluorescence staining shows a robust increase in myoblast proliferation in the presence of rGDF-15 in primary myoblasts. Representative images from
untreated and 750 ng/ml rGDF-15–treated myoblasts are shown. Scale bars in the upper left corner represent 100 μm. (E) Proliferation index of primary
myoblasts in the presence of indicated concentrations of recombinant GDF-15 (n = at least 6 independent experiments). (F) Immunofluorescence against
Desmin (red) and DAPI (blue) shows no difference in myotube formation in the presence of rGDF-15 in primary myoblasts (n = 12 independent experiments).
Representative images from untreated and 750 ng/ml rGDF-15–treated myoblasts are shown. Scale bars in the upper left corner represent 100 μm. (G) Fusion
index of primary myoblasts in the presence of various concentrations of recombinant GDF-15 (n = at least 6 independent experiments). (H) Number of in-
filtrating CD45+ cells in TA muscle of WT mice administered with saline (control) or rGDF-15 (30 µg/kg intramuscularly) at day 2 after CTX injury (n = 4
biologically independent samples per treatment group). (I) Frequency (in %) of CD45+ F4/80+ MHCII+ MFs from saline (control) and rGDF-15–treated animals at
indicated time points following CTX injury (n = 5 mice per group). (J) Representative flow cytometry 10% quantile contour plots of CD45+ F4/80+ MHCII+ MFs
from vehicle (saline) and rGDF-15–treated animals at days 2 and 4 after CTX injury. Images represent four independent experiments with similar results. x and y
axis numbers indicate the fluorescence intensity (on the log10 scale) of the indicated fluorescent-labeled antibodies for all the plotted events. PB, Pacific Blue;
APC, allophycocyanin. (K) Frequency (in %) of inflammatory (Ly6Chigh F4/80low) and repair (Ly6Clow F4/80high) MFs from vehicle (saline) and rGDF-15–treated
(30 µg/kg intramuscularly) animals at day 4 following CTX injury (n = 5 mice per group). (L) Average fiber CSA of regenerating muscle in saline (control) and
rGDF-15–treated (30 µg/kg intramuscularly at day 4) animals at day 8 after CTX injury (n = 10 per group). In all bar graphs, bars represent mean ± SEM. Exact P
values were determined using unpaired Student’s t test or ANOVA to compare three or more groups, *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001.
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Figure 5. Gdf15 is a PPARγ and RXRα regulated gene. (A) Identification of PPARγ and RXRα regulatory elements around the Gdf15 locus. Genome browser
view of ATAC-seq signals from muscle-derived MFs at the indicated genomic region (Gdf15 locus) showing peak intensities and DR1 predicted motifs scores. De
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subpopulations present in these mice via FACS, we observed an
increased frequency of Ly6Clow F4/80high (Fig. 6, L and M, top)
and a lower frequency of MHCII+ (Fig. 6 M, bottom, and Fig. 6 N)
repair MFs at day 4 after injury. These results suggest that while
GDF-15 expression is altered and likely contributes to the ob-
served increased infiltration phenotype, RXRα/β-deficient muscle-
MFs have an impaired ability to retain the inflammatory phenotype
(most likely due to the cumulative impact of the dysregulation of
multiple important genes that are under RXR control), resulting in
an inability to clear necrotic fibers, and a premature shift to the
Ly6Clow repair phenotype. It has been established that if themyeloid
cell subpopulation’s orderly transition is impacted in either direc-
tion, it will lead to a defect in regeneration, as seen in other models
(Patsalos et al., 2019).
GDF-15 marks a novel repair MF subpopulation with a
functionally distinct effector-expressing signature at the
single-cell level
Due to the large heterogeneity of the regenerating cell milieu (De
Micheli et al., 2020), we asked (1) if the source(s) of GDF-15 is
(are) all repair MFs or a subpopulation and (2) whether the RPP
(involving clusters 2 and 5; Fig. 1, E–H) we observed by profiling
sorted monocytes and MFs, marked by genes such as Gdf15 and
Igf1, can be assigned to one ormultiple groups of cells. To address
these questions, we performed droplet-based single-cell 39 RNA-
seq in CD45+ cells isolated from CTX-injured tibialis anterior
(TA) muscles at day 4. We used the Seurat package for scRNA-
seq data filtering and processing (see Materials and methods).
Briefly, we removed cells with <200 genes detected, <1,000
unique molecular identifiers (UMIs), or >5% of UMIs mapped to
mitochondrial genes (Fig. S5 A, left). Applying these filters
eliminated dying cells and doublets presented as outliers with
>30,000 UMIs. After filtering, the scRNA-seq dataset contained
7,103 cells, expressing a total of 16,979 different genes (Fig. S5 A,
right). We then performed unsupervised shared nearest neigh-
bor (SNN) clustering, which partitioned cells into 12 groups
based on their transcriptomic programs after optimizing the
SNN resolution parameter by silhouette analysis (Fig. S5 B).
Next, we annotated the cell types present in this dataset rep-
resenting the entire immune cell milieu of the regeneration
phase following injury (Fig. 7 A). Identification of cell types from
SNN clusters was based on cluster-average expression of ca-
nonical genes included in the EnrichR Mouse Gene Atlas (Chen
et al., 2013; Kuleshov et al., 2016). As expected, the cumulatively
largest and most ambiguous group is MFs (76.9% of the total
single-cell transcriptomes; Fig. 7 A, right), classified by the ex-
pression of known MF markers like F4/80 (Adgre1), Aif1, and
Mertk (Fig. 7 B). To further discriminate the ambiguous pop-
ulations, we also performed differential gene expression analy-
sis between cells within each group and all other cells in the
dataset (Fig. 7 C and Fig. S5 C). Both analyses revealed four
different subtypes of MFs with varying cell number composition
and unique gene expression profiles (Fig. 7, A–C). We labeled
them as types I, II, III, and IV and focused our analysis on these
four cell populations (Fig. 7 B). Next, we asked (1) what markers
define these distinct MF subtypes, (2) whether we can draw
conclusions on the potential function of these four different
states of MFs based on their unique gene expression patterns,
and (3) whether Gdf15 has any distinct expression pattern within
these MF populations. Interestingly, Gdf15 was predicted un-
biasedly as one of the specific markers for the type II MFs (Fig. 7
C). Significantly, the majority of this repair MF subset is positive
for Pparγ and Rxrα but also for the majority of other known
secreted growth factors, including Igf1 and Gdf3 (Fig. 7 D). Type I
MFs, the largest MF group, are defined by high expression of MF
maturation markers like Mertk, but also seem to exclusively
express several enzymes involved in the production of pro-
resolving lipid mediators like Hpgd, Hpgds, and Pla2g15, as
well as Apoe and Tgfbr1, characteristic of the M2-like anti-
inflammatory phenotype (Baitsch et al., 2011; Ho et al., 2016;
Ho et al., 2017; Giannakis et al., 2019), and thus most likely
involved in the resolution phase of the regenerative response
(Fig. 7, C and D). Type III MFs, the smallest group, seem to be
the remaining pro-inflammatory monocytes/MFs with high
expression of inflammatory monocyte markers Ly6c2, Sell, Ace,
and Hp, while type IV MFs seem to have higher antigen-
presenting capacity characterized by expression of classical
MHCII proteins, such as Cd74 and the H2 family, as well as
C-type lectins like Mgl2 (Fig. 7 D; Denda-Nagai et al., 2010;
Panduro et al., 2018). Interestingly, we also found that 98.08%
of the genes expressed in the RPPs of clusters 2 and 5 (defined
in Fig. 1 E) are detected in the four MF subtypes identified by
scRNA-seq analysis. More specifically, cluster 2 genes (700 out
of 716, 97.7%) with a steadily decreasing expression pattern
show a predominance for MF type III (functionally annotated as
a pro-inflammatory subtype), while cluster 5 genes (936 out of
952, 98.3%) with a steadily increasing expression pattern along
the regeneration time course show a predominance for type I
(functionally annotated as resolution-related MFs) and II MFs
(functionally annotated as the GFEM subtype; Fig. 7 E). In a
novo motif scores (HOMER) are shown on a table on the right (relative profile score threshold >95%). Arrows indicated the regions upstream of the TSS
selected for the in silico motif prediction. The exact motif sequence, highlighting the nuclear receptor (NR) half sites including the 59 extension, are shown.
(B) PPARγ and RXRα bind to proximal regulatory elements around the Gdf15 locus. Genome browser view of the Gdf15 locus with the indicated ChIP-seq
experiments performed in WT BMDMs. ChIP-seq experiments for RNAPII-pS2 were performed in the presence of the indicated nuclear receptor ligands.
(C) Quantification of Gdf15 gene expression (mRNA) using qPCR in WT BMDMs treated with the indicated nuclear receptor agonists (n = 3 biological replicates
per treatment group). (D) eRNA measurements of putative enhancer regions around the Gdf15 locus in WT BMDMs treated with PPARγ or RXR agonists (n = at
least 4 independent experiments). (E) Quantification of Gdf15 gene expression (mRNA) using qPCR inWT-control and Rxrafl/fl Rxrb−/−LysM-Cre BMDMs treated
with indicated ligands individually or in combination (n = 3 biological replicates per treatment group). (F) Quantification of Gdf15 and Gdf3 gene expression
(mRNA) using qPCR in WT BMDMs treated with the indicated nuclear receptor agonists individually or in combination (n = at least 3 biological replicates per
treatment group). Both genes were normalized over Ppia (n = 3 independent experiments). In all bar graphs, bars represent mean ± SEM. Exact P values were
determined using unpaired Student’s t test or ANOVA to compare three or more groups. *, P < 0.05; ***, P < 0.001; ****, P < 0.0001.
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Figure 6. Skeletal muscle regeneration is impaired in myeloid RXRα/β-deficient animals. (A) Representative images of H&E-stained skeletal muscle (TA)
from WT-control and Rxrafl/fl Rxrb−/−LysM-Cre animals at day 8 after CTX-induced injury are shown. Scale bars in the upper left corner represent 100 µm.
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complementary analysis, we applied the single-cell regulatory
network inference and clustering (SCENIC) workflow on our
dataset (Aibar et al., 2017; Van de Sande et al., 2020). This
analysis provides insight into the transcriptional regulators
that define the identity of cell types constituting the re-
generating cell milieu (Fig. 8). Binarization of the AUCell scores
(see Materials and methods) for the predicted regulators and
subsequent clustering of the cell-regulon matrix reveals clus-
ters of regulators characteristic of each MF subtype and thus
potential mechanisms driving cellular heterogeneity (Fig. 8).
The prediction of cell states is based on the shared activity of
regulatory subnetworks. For example, the regulators Cebpb,
Maf, and Spi1 (PU.1) are defining the identity of the entire MF
compartment, thus validating the predictions of the SCENIC
workflow (Fig. 8). Significantly, regulons based on RXRα and
Cebpa are active only in MFs associated with growth factor–
expressing (type II, dark blue) and anti-inflammatory functions
(type I, orange). In addition, the cluster of pro-inflammatoryMFs
(type III, gold) contains a unique set of regulators that includes
Irf9, Ikzf1, and Stat2, while Ehf, Stat5a, and Bcl11a show high
activity in MFs with increased antigen-presenting capacity (type
IV, light blue). This analysis predicts RXR unbiasedly as a direct
regulator of the GFEM subtype and further implicates this
pathway and subsequently its targets as a defining regulatory
network during regeneration. In summary, by testing the hy-
pothesis that GDF-15 can predict the core effector repair signa-
ture at the single-cell level, we identified Gdf15-expressing
immune cells as a novel and distinct repair MF subpopulation of
the myeloid-driven regeneration cellular ecosystem, hereby
termed GFEMs. In addition, the SCENIC workflow predicts RXRa
as one of the core regulators (and the only signal-dependent TF)
of the GFEM transcriptional program.
As an additional proof of concept and to validate these results
at the protein level, we decided to test whether a predicted cell
surface marker (based on the scRNA-seq dataset) could distin-
guish the GFEMs from the rest of the MF subtypes by FACS. We
chose a top predicted cell surface marker protein called GPNMB
(also known in the literature as osteoactivin) for further analysis
(Fig. 7 F). Notably, Gpnmb was also predicted as a top DE gene
with effector functions during the day 4 Ly6Clow MF versus
blood monocytes comparison (Fig. 2, A and B) and is ranked
among the top 10 genes with the highest counts per million
(CPM) values overall in the entire day 4 Ly6Clow RNA-seq da-
taset (Fig. S5 D). It also belongs to cluster 5 following Gdf15 and
Igf1 gene dynamics (Fig. 1, E and H; Fig. 2 E; and Fig. S5 D). FACS
analysis at this time point on Gdf15KOmice using the cell surface
expression of GPNMB as an additional marker of MF subtype
specification suggests an impairment in the formation of the
GFEM population (Fig. 7 G). These findings also suggest that
GPNMB expression can accurately predict and thus validate the
presence and abundance of type II MFs (GFEMs) detected in the
scRNA-seq data (∼18.5%) when gated for its cell surface protein
expression on CD45+ Ly6Clow F4/80high repair MFs at day 4 after
CTX (Fig. 7 H). To further validate that GPNMB is a bona fide
marker of type II MFs (GFEMs), we FACS-sorted CD45+ Ly6Clow
F4/80high Gpnmb+ and CD45+ Ly6Clow F4/80high Gpnmb− repair
MFs at day 4 after CTX (Fig. 7 H) and quantified the expression
of predicted GFEMmarkers (Fig. 7 C) such as Cd36, Gdf15, Gpnmb,
Igf1, and Rxrα by qPCR (Fig. 7, I and J). Notably, all these pre-
dicted markers are expressed well above the median expression
(based on CPM values) of any gene in the day 4 Ly6Clow repair
MF RNA-seq dataset (Fig. S5 D). Collectively, these results val-
idated the existence of the GPNMB+ Ly6Clow F4/80high repair MF
subpopulations.
In summary, our data show (1) that the PPARγ–RXR–GDF-15
axis is a novel and essential component of MF-mediated skeletal
muscle repair by acting locally in a paracrine and autocrine
manner, and (2) that GDF-15 marks and is exclusively expressed
by a novel and functionally distinct MF subtype, GFEM, within
the regenerating cell milieu.
Discussion
The immune system is emerging as a critical regulator of many
physiological processes, including skeletal muscle regenera-
tion. Although several distinct and isolated immune-mediated
(B) Necrotic fiber area percentage relative to the regeneration area at day 8 after CTX in control (Rxrafl/fl Rxrb−/−) and Rxrafl/fl Rxrb−/−LysM-Cre, muscles (n = at
least 20 muscles per group). (C) Average fiber CSA of regenerating muscle at day 8 after CTX injury in WT-control and Rxrafl/fl Rxrb−/− LysM-Cre animals at day
8 after CTX injury (n = 5 or 6 mice per group). (D) Representative images of H&E-stained skeletal muscle (TA) from day 21 post–CTX injury WT-control and
Rxrafl/fl Rxrb−/−LysM-Cre animals. Scale bars in the upper left corner represent 100 µm. (E) Average fiber CSA at day 21 after CTX injury in muscles from WT-
control and Rxrafl/fl Rxrb−/−LysM-Cre animals (n = 8 mice per group). (F)Muscle to body weight ratio at day 21 after CTX injury in muscles fromWT-control and
Rxrafl/fl Rxrb−/−LysM-Cre animals (n = 7 or 8 muscles per group). (G) Representative images of H&E-stained skeletal muscle (TA) from uninjuredWT-control and
Rxrafl/fl Rxrb−/−LysM-Cre animals. Scale bars in the upper left corner represent 100 µm. (H) Average fiber CSA of uninjured muscle WT-control and Rxrafl/fl
Rxrb−/−LysM-Cre animals (n = 6 mice per group). (I) Gdf15mRNA expression in WT-control and Rxrafl/fl Rxrb−/−LysM-Cre repair MFs (Ly6Clow F4/80high) sorted
at day 4 after injury. Gdf15 was normalized over Ppia (n = 3 independent experiments). (J) GDF-15 protein expression in whole-muscle lysates of regenerating
muscles from control (respective floxed control littermate), Rxrafl/fl Rxrb−/−LysM-Cre, and Pparγfl/fl LysM-Cre KOmice at day 4 after CTX. Signal quantification is
shown in the upper panel. Ponceau Red staining was used for loading control and signal normalization (n = 3mice per group). (K)Number of infiltrating myeloid
(CD45+) cells in regenerating muscle fromWT-control and Rxrαfl/fl Rxrβ−/− LysM-Cre animals at day 4 after CTX injury (n = 5 mice per group). (L) Percentage of
inflammatory (Ly6Chigh F4/80low) and repair (Ly6Clow F4/80high) MFs fromWT-control and Rxrafl/fl Rxrb−/−LysM-Cre muscles at day 4 following CTX injury (n =
8 mice per group). To determine P values, two-way ANOVA with multiple comparison test was used. (M) Representative flow cytometry 10% quantile contour
plots of inflammatory and repair MFs fromWT-control and Rxrafl/fl Rxrb−/−LysM-Cre muscles at day 4 after CTX injury. Shapes indicate the gating used for cell
frequency quantification (square = Ly6Chigh inflammatory MFs, circle = Ly6Clow repair MFs, rectangle = MHCII+ MFs). Representative frequencies for each cell
population are shown adjacent or inside each gate. x and y axis numbers indicate the fluorescence intensity (on the log10 scale) of the indicated fluorescent-
labeled antibodies for all the plotted events. PE, phycoerythrin; PB, Pacific Blue; AF488, Alexa Fluor 488. (N) Frequency (in %) of CD45+ F4/80+ MHCII+ MFs
from WT-control and Rxrafl/fl Rxrb−/− LysM-Cre mice at day 4 following CTX injury (n = 8 mice per group). In all graphs, bars and lines represent mean ± SEM.
Exact P values were determined using unpaired Student’s t test unless otherwise noted. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001.
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Figure 7. scRNA-seq analysis of CD45+ cells at day 4 after injury reveals the myeloid cell source of GDF-15. (A) Single-cell transcriptomes derived from
CD45+ cells isolated from injured TA muscle at day 4 after CTX injury. A total number of 7,103 cells expressing 16,979 different genes were used for the
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mechanisms have been described in recent studies (Serrano
et al., 2008; Ruffell et al., 2009; Perdiguero et al., 2011; Deng
et al., 2012; Mounier et al., 2013; Tonkin et al., 2015; Corna et al.,
2016; Varga et al., 2016b; Patsalos et al., 2017; Patsalos et al.,
2019; reviewed recently by Juban, 2021), the full-fledged
dynamic aspects of the regenerative immunity as manifested in
MF phenotype specification, as well as the potential existence
of a specific RPP, remain elusive. In this study, (1) we per-
formed a comprehensive bulk transcriptomic analysis of in-
flammatory monocytes and derived MF subpopulations; (2) we
downstream analysis. Data are presented as a t-distributed stochastic neighbor embedding (tSNE) projection to visualize variation in single-cell transcriptomes.
Unsupervised SNN clustering resolved at least 12 distinct types of cells (color-coded in legend) and was achieved using a hierarchical tree algorithm (Seurat’s
Leiden algorithm). Identification of cell types from SNN clusters was based on cluster-average expression of canonical genes included in the EnrichR Mouse
Gene Atlas (Chen et al., 2013; Kuleshov et al., 2016). The composition of cell types presented as a percentage, as well as the absolute number of cells per
identified cluster, are shown on the right. The cumulatively largest and most ambiguous group are F4/80+ MFs (consisting of 76.9% of the total single-cell
transcriptomes). (B) Left: Feature plots of classical MF-defining markers (Adgre1, Aif1, MerTK) across all cells (row Z-score). Right: tSNE plot of single-cell
transcriptomes representing the clusters of only the F4/80 (Adgre1)+ cells. (C) Top 15 marker genes for the four identified MF clusters. The dot size represents
the percentage of cells within a group with an expression level >0, and color-scale represents the average expression level (row Z-score) across all cells within
the cluster (determined by nonparametricWilcoxon rank-sum test). (D) Single-cell expression levels (row Z-score) for selected functional MFmarkers based on
prior literature (Varga et al., 2016a; Varga et al., 2016b; Tidball, 2017; Chazaud, 2020). These markers allowed delineation of four functionally distinct MF
subtypes at day 4 after injury. (E) Average expression of all genes included in the RPPs of clusters 2 and 5 (defined in Fig. 1 E) in the four MF subtypes identified
by scRNA-seq analysis. Cluster 2 genes (700 out of 716) with a stably decreasing expression pattern show a predominance for MF type III (functionally an-
notated as a pro-inflammatory subtype), while cluster 5 genes (936 out of 952) with a stably increasing expression pattern along the regeneration time course
show a predominance for MF type I and II (functionally annotated as resolution-related and growth factor–expressing subtypes, respectively). (F) Feature plot
of Gpnmb expression (row Z-score) defining the MF type II that corresponds to the functionally annotated GFEM subtype. (G) Frequency (in %) of CD45+
inflammatory (Ly6G− Ly6Chigh F4/80low GPNMB+) and repair (Ly6G− Ly6Clow F4/80high GPNMB+) MFs from WT-control and Gdf15 KO mice at day 4 following
CTX injury (n = 4 mice per group). Bars represent mean ± SEM. Exact P values were determined using unpaired Student’s t test. *, P < 0.05; ***, P < 0.001.
(H) Representative FACS 10% quantile contour plots and gating strategy of CD45+ Ly6Clow GPNMB+ F4/80+ MFs at day 4 after CTX in control mice, rep-
resenting the GFEM subtype. x and y axis numbers indicate the fluorescence intensity (on the log10 scale) of the indicated fluorescent-labeled antibodies for all
the plotted events. AF488, Alexa Fluor 488. (I and J) Heatmaps showing the relative mRNA expression (assessed by qPCR and visualized as log relative
expression [Rel. Expr.] values over Ppia) pattern of GFEM predicted marker genes in (I) Ly6Chigh or Ly6Clow muscle-infiltrating MFs and (J) FACS-sorted CD45+
Ly6Clow GPNMB+ F4/80+ and CD45+ Ly6Clow GPNMB− F4/80+ MFs. mRNA expression values reflect the average of three biological replicates per population.
“Gpnmb v1” and “Gpnmb v2” reflect two separate primer sets targeting different exons of the Gpnmb gene.
Figure 8. SCENIC reveals RXR regulon activity in reparatory MFs (GFEM and resolution-related MFs). Binary activity for each cell is generated from the
SCENIC area under curve distribution and plotted as a heatmap, with black (left) or red (right) blocks representing cells that are “on.” For selected MF subtypes
(right), the figure depicts regulators. The number of predicted target genes is also given for each regulator. The annotated cell populations are color-coded as in
Fig. 7 A. For example, the regulons based on RXRα (highlighted) and Cebpa are active only in MFs associated with growth factor–expressing (type II, dark blue)
and anti-inflammatory functions (type I, orange). The knownMF regulators Cebpb, Maf, and Spi1 (PU.1) are defining and validating the identity of the entire MF
compartment. The cluster of pro-inflammatory MFs (type III, gold) contains a unique set of regulators that include Irf9, Ikzf1, and Stat2. Ehf, Stat5a, and Bcl11a
show high activity in MFs with increased antigen-presenting capacity (type IV, light blue).
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identified two clusters of genes with steadily and continuously
increasing/decreasing expression levels from circulating mono-
cytes culminating in repair promoting MFs, suggesting that
signaling events drive the repair phenotype without evidence of
transitions between pro-inflammatory and pro-regenerative
phenotypes; (3) as a component of it, we have uncovered the
PPARγ–RXR–GDF-15 axis as a novel and essential component of
MF-mediated skeletal muscle repair by acting locally in a para-
crine and autocrine manner; and (4) by using scRNA-seq, we
validated that Gdf15 along with other regeneration-promoting
factors mark and are predominantly expressed by a novel and
functionally distinct GFEM subtype within the regeneration-
associated myeloid cell population, as the product of the RPP.
Dynamically changing MF phenotypes as the result of plas-
ticity are a leading paradigm in innate immunology. They ex-
plain the phenotypic transition from circulating monocytes to
inflammatory Ly6Chigh and then to repair Ly6Clow MFs, a pro-
cess highly correlated with the tissue regeneration kinetics.
These transitions are accompanied by a dynamic crosstalk be-
tween MFs and other muscle tissue components driven by a
transcriptional reprogramming process. To our knowledge, this
is the first time circulating monocyte profiling, and multiple
time points using the most inclusive MF gating strategy, are
taken into consideration simultaneously for a more compre-
hensive analysis of the MF phenotypic and functional state
continuum. There is also strong evidence that the indicated time
points we selected reflect all phases of regeneration (pro-in-
flammatory, resolution, and repair phases) and at the same time
provide sufficient cell numbers to perform the RNA-seq immune
profiling (Giannakis et al., 2019; Patsalos et al., 2021). The
aforementioned switches in MF phenotype have been docu-
mented by multiple transcriptomic, epigenomic, lineage tracing,
and lipidomic approaches by several laboratories, including ours
(Perdiguero et al., 2011; Mounier et al., 2013; Varga et al., 2013;
Wang et al., 2014; Tonkin et al., 2015; Varga et al., 2016a;
Panduro et al., 2018; Giannakis et al., 2019; Patsalos et al., 2019).
These findings collectively suggest that the successive immune
cell states from circulating inflammatory monocytes via in-
flammatory MFs to repair type MFs can be interpreted as a hi-
erarchical continuum of cell states (Novak and Koh, 2013).
However, it remains to be resolved how effectors, regulatory
factors, and surface markers define this monocytic/MF contin-
uum and where cells isolated from acute sterile muscle injuries
fall in this spectrum. It was also an open question if there are
additional functionally distinct cellular subtypes. Our work goes
a considerable distance toward answering these questions. We
used bulk RNA-seq to take advantage of its superior sensitivity
and robustness to detect low copy number mRNA species
(i.e., TFs) compared with single-cell approaches on sorted cir-
culating monocytes and muscle-infiltrating MFs isolated from a
comprehensive set of time points after CTX injury. We detected
transcriptional programs with transiently or steadily changing
dynamics. The transient nature of some of the changes (such as
the several thousands of genes represented in clusters 1, 3, 4, 6,
and 7) is not very surprising because it represents switches from
unstimulated to inflammatory states and back to the opposing
repair or anti-inflammatory/resolution state. However, the
existence of clusters 2 and 5 representing >1,600 protein-coding
genes steadily up- or down-regulated over this continuum of
cellular states and over the time course is not compatible with a
simple switch forward and then backward model of gene ex-
pression. This intriguing finding prompted us to ask the fol-
lowing questions: (1) What are the effectors that participate in
the steadily changing RPP transcriptional programs? (2) How do
these effectors contribute overall to the MF phenotype switch
during muscle regeneration? And (3) how are they regulated at
the transcriptional level? Using the expression pattern of well-
established repair growth factor Igf1 as a benchmark or guide, we
narrowed down our studies to the MF-secreted growth factor
GDF-15, using it as a proof-of-concept that could act as an ef-
fector of myoblast and MF activity, similar to IGF-1, and would
initiate a sequence of events as part of a regulatory axis with
PPARγ and RXRα. The timing and localization of GDF-15 in the
CTX injury model firmly suggested that GDF-15 is a general, MF-
specific regulator of muscle regeneration.
To our knowledge, only seven other gene deletion para-
digms, DUSP1, AMPKa1, BACH1-HMOX1, Metrnl-STAT3, NFIX,
C/EBPβ–IL-10 or IGF1 deficiency in muscle-infiltrative MFs,
were reported to lead to altered MF phenotype switch (Ruffell
et al., 2009; Perdiguero et al., 2011; Mounier et al., 2013; Tonkin
et al., 2015; Patsalos et al., 2019; Baht et al., 2020; Saclier et al.,
2020; Welc et al., 2020). However, the molecular mechanism of
the MF phenotypic switch mediated by GDF-15 remains to be
fully elucidated. Based on our findings, GDF-15 expression can
be potentially used as a marker of the phenotype switch from
inflammatory to repair MFs, reflecting a functional difference
in growth factor secretion and antigen-presenting status be-
tween the two distinct repair MF subtypes. In addition, our
in vitro results with primary myoblasts suggested the presence
of a regulatory circuit between MFs and muscle cells. Indeed,
exogenous GDF-15 appeared to be an especially robust enhancer
of myoblast proliferation, while local administration of rGDF-15
in vivo leads to a subtle but significant increase in the antigen-
presenting capacity of repair MFs. From a physiological perspec-
tive, the MHCII increase could also either signify the terminal
maturation of repair MFs or confer protection from a potential
subsequent infection (Jin et al., 2018). Circulating Ly6Chigh
monocytes that enter the tissue during inflammation or injury
differentiate into repair and anti-inflammatory MFs or pro-
inflammatory and immune-stimulatory DCs (Geissmann et al.,
2010). They express CD11c and CD11b and exhibit some antigen-
presenting activity, althoughmuch less than CD103+ DCs (Stables
et al., 2011; Ramachandran et al., 2012; Rivollier et al., 2012;
Zigmond et al., 2012). Thus, the ability of GDF-15 to impact
functional features and potentially the differentiation of mono-
cytes or DCs has important ramifications on immunity and tissue
homeostasis. In this context, it will be important to uncover
receptors and pathways that enable and mediate the activity of
GDF-15 within distinct cellular compartments after its secretion.
In addition, as other cell types are also involved in the regen-
eration process (Joe et al., 2010; Uezumi et al., 2010; Heredia
et al., 2013), it cannot be excluded that GDF-15 has effects on
other cell types such as fibro/adipogenic progenitors (Hidestrand
et al., 2008; Joe et al., 2010; Lemos et al., 2015). However, a key
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component of the signaling, the receptor(s) of GDF-15, remains
elusive. Given the wide associations of GDF-15 with a variety of
biological processes, including pregnancy, metabolism, and in-
flammation, it is very likely that GDF-15 plays additional roles to
those described in our studies (Tsai et al., 2018; Patel et al., 2019;
Breit et al., 2021) and may act on multiple different low(er) af-
finity receptors on different cell types and in concert with other
bone morphogenic proteins or TGF-β family members, as has
been demonstrated and postulated for these proteins (Antebi
et al., 2017). Some of these receptors, like Tmed1, are ex-
pressed in cells present during muscle regeneration (McKellar
et al., 2020 Preprint). It is also possible that its high-affinity re-
ceptor, GFRAL (Mullican et al., 2017; Yang et al., 2017), may be
expressed on other rare cell types outside of the area postrema in
the brain, or more likely, additional receptors for GDF-15 may
exist but have not yet been discovered. Identifying these re-
ceptors and the potential interaction with other TGF-β family
members would further increase our understanding of the roles
of GDF-15 in physiology and pathology and potentially allow the
identification of novel therapeutic targets for regenerative
immunotherapy.
The family of GDFs, like GDF-3 and GDF-15, are secreted ef-
fectors with pleiotropic functions in different tissues and or-
gans. However, they are among the few growth-promoting
factors released locally bymuscle-infiltrating inflammatory cells
to trigger and control the distinct actions of satellite cells
throughout the myogenic process. GDF signaling has been pre-
viously associated with stimulation of hypertrophic muscle
growth and myogenesis by regulating the proliferative and dif-
ferentiation capacity of muscle stem cells. Overall, they have
been characterized as regulators of muscle development, ho-
meostasis, and regeneration (Varga et al., 2016b; Kleinert et al.,
2018; Gil et al., 2019; Assadi et al., 2020; Borner et al., 2020; Breit
et al., 2021; Laurens et al., 2020). Paradoxically, global, poten-
tially maladaptive actions for GDF-15 have also been proposed,
such as promotion of atrophy, malaise, and muscle wasting
(Johnen et al., 2007; Tsai et al., 2018; Patel et al., 2019). Such a
dichotomy is not uncommon with cytokines and growth factors,
molecules that are, by definition, pleiotropic (i.e., IL-6 and IGF-1).
For example, IL-6, principally defined as a proinflammatory cy-
tokine in the circulation, is also one of the few genuine myo-
kines produced by and/or acting on skeletal muscle (Hirano,
1998; Muñoz-Cánoves et al., 2013). In regenerating muscle, IL-6
produced locally by various cell types, including infiltrating
MFs, has a positive impact on the proliferative capacity of
muscle stem cells, similar to GDF-15 (Serrano et al., 2008). This
local physiological mechanism functions to provide sufficient
muscle progenitors under circumstances that require a high
number of these cells, such as following injury. These positive
effects are typically associated with their transient production
and short-term action. On the contrary, persistent inflammatory
conditions and other chronic disease states (i.e., cancer) are as-
sociated with elevated systemic levels that are long-lasting. In
such situations, the actions of these molecules are coupled with
increased muscle wasting, very often acting in combination with
other molecules or functioning indirectly to promote atrophy.
Elevated levels of circulating IL-6 are believed to be mediating
the tumor cachexia phenotype, including muscle wasting
(Strassmann et al., 1992; Zhang et al., 2009). Thus, our findings
uncovered a local mode of action for GDF-15 consistent for being
both an endocrine and paracrine growth factor, similar to IL-6
and IGF-1. Circulating IGF-1 is mainly produced by the liver and
acts as the primary mediator of growth hormone–dependent
growth, as an important mitogenic factor regulating growth,
nutrient metabolism, reproduction, and aging, while local IGF-
1 is produced by peripheral tissues acting as a paracrine/auto-
crine factor for local tissue growth (Stuard et al., 2020).
The nature and biological significance of GDF-15 in muscle
regeneration are further supported by the two lines of our
molecular investigations. First, regarding the upstream regu-
lators, from the perspective of muscle regeneration, we consider
themost important finding to be the identification of GDF-15 as a
regeneration factor, which is subject to robust regulation by
PPARγ and RXRα in all relevant MF subtypes. To ascertain that
GDF-15 is indeed a direct transcriptional target, we analyzed an
extensive range of genomic and epigenomic data. GDF-15 is
expressed in an RXRα/PPARγ-dependent fashion and can be
induced by specific RXRα/PPARγ synthetic ligands in BMDMs
but does not belong to the group of canonical PPARγ-regulated
genes (such as Angptl4 or Fabp4) described in earlier myeloid
cell–related studies (Welch et al., 2003; Szanto et al., 2010). This
level of detail goes much beyond what has been known re-
garding ligand regulation of GDF-15 in unrelated cell types and
in silico predictions (Baek et al., 2004; Suzuki et al., 2006; Araki
et al., 2009; Yu et al., 2010; Hofer et al., 2018). In parallel, recent
reports suggested cell metabolism as a defining factor in MF
identity and functional status (Vats et al., 2006; Odegaard and
Chawla, 2011; Lavin et al., 2014; Okabe and Medzhitov, 2014).
PPARγ and RXRα are metabolic sensors and regulators con-
trolling several effector genes implicated in MF polarization
(Daniel et al., 2018) and muscle regeneration (Varga et al.,
2016b). Thus, the role of the RXR signaling pathway is intrigu-
ing and goes beyond this gene alone. It covers a network of genes
as identified using the SCENIC approach. We have previously
reported that GDF-3 is dependent on the presence of PPARγ
(Varga et al., 2016a). Moreover, several other genes from clus-
ters 2 and 5 are likely to be subject to regulation by these nuclear
receptors. This raises the intriguing possibility that this signal-
ing pathway is one of the drivers of the repair phenotype and
thus of the RPP. This also implies that lack of RXR in MFs is
likely to have a broader effect on regeneration, which is the sum
of all the altered gene expression events and not necessarily a
phenocopy of GDF-15 deficiency. Second, regarding the cell type
selectivity of GDF-15 expression, our results indicate that repair
MFs are the predominant, if not the only, source of GDF-15
within the injured tissue. To validate this finding, we used ex-
pression profiling at the single-cell level to fully resolve the
heterogeneity and cellular complexity and further understand
the different functions of each MF subset. This effectively
complemented and extended our bulk RNA-seq analyses. Our
scRNA-seq suggests that these effectors are expressed simulta-
neously and in a stage-specific manner within GFEM. Their
expression is specific and highest in this cell population but not
selective or exclusive.
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Recent studies presented transcriptomic atlases of re-
generating muscle, focusing on satellite and progenitor cells
from homeostatic and toxin-injured muscles (Dell’Orso et al.,
2019; De Micheli et al., 2020; Oprescu et al., 2020). Here, we
present an annotated and comprehensive single-cell tran-
scriptomic immune dataset of the regeneration phase following
injury with over 7,000 single-cell transcriptomes with an av-
erage of 3,808 expressed genes per cell, adding to the growing
repository of scRNA-seq datasets in skeletal muscle regeneration
and complementing, but not replacing, the bulk RNA-seq data
presented above. Our scRNA-seq analyses confirm prior con-
sensus regarding the immune cell populations involved in the
temporal response to muscle injury and provide a deeper an-
notation of additional immune cell types, subpopulations, and
states with higher resolution, compared with prior scRNA-seq
studies (12 different cell types via SNN clustering), including
four novel and likely functionally distinct MF subtypes. In our
unbiased analysis, we followed an elaborate workflow to iden-
tify the number of clusters and marker genes based on multiple
bioinformatic packages, including but not limited to the most
widely used, named Seurat by the Satija laboratory (Butler et al.,
2018). However, many of these clustering workflows rely on
user-tuned parameter values that need to get tailored to each
dataset, which is one of the major computational limitations
in the analysis of single-cell datasets. To address this issue, we
took an independent approach to determine cluster resolution
by using a subsampling-based approach (chooseR) that was
recently published and simultaneously guides parameter se-
lection while characterizing cluster robustness (Patterson-
Cross et al., 2021). In addition, we applied manual marker
selection as well as automated cell annotation pipelines (SingleR)
that perform unbiased cell type recognition by leveraging ref-
erence transcriptomic datasets of pure cell types to infer the cell
of origin of each single cell independent of clustering, ensuring
that we do not overcluster our cell types and subtypes (Aran
et al., 2019). These unbiased analyses firmly pointed to the ex-
istence of four MF clusters at day 4 after CTX. We found that
GDF-15, and other growth factors like IGF-1 and GDF-3, are
highly expressed in a distinct repair-MF subpopulation we
termed growth factor–expressing macrophages (GFEMs). Fur-
thermore, we characterized this repair-MF subset by FACS using
a predicted and highly enriched cell surface molecule (GPNMB),
which is again a specific but not exclusive marker of this subset.
Future studies could use functional as well as a cytometry by
time of flight dataset composed of several markers to provide
an orthogonal validation of MF subtypes and their surface
receptor expression variability during the time course of re-
generation. Trajectory analysis could also allow parsing the
MF differentiation and subtype specification after injury in
distinct states like anti-inflammatory/resolution–related, growth
factor–secreting, pro-inflammatory, and antigen-presenting,
with diverse gene expression signatures, as recently hy-
pothesized (Patsalos et al., 2021).
The mechanistic role of GDF-15 in regulating myoblast signal
transduction in the context of regeneration remains poorly
understood. Several reports suggest that GDFs may serve as li-
gands that interplay with numerous ligand-receptor systems
involved in myogenic cell fate regulatory pathways (Heldin and
Moustakas, 2016). Future studies will take advantage of the
available technology that allows the selective interference with
GDF-15 production, GDF-15 receptors, and downstream signaling
in specific cell types at a desired experimental stage to fully
decipher the contribution of GDF-15 in different contexts. This
knowledge will also potentially allow selective interference of
the deleterious actions of GDF-15 in pathological contexts and
promotion of the beneficial effects of GDF-15 for therapeutic
purposes. There are several additional questions raised by our
study. What other effects are induced by GDF-15, and how do
they affect acute and chronic regenerative inflammation out-
comes? What are the regulatory factors that coordinate the
production of key growth factors? Finally, the therapeutic ap-
plicability of this pathway is yet to be determined.
Taken together, PPARγ/RXRα–controlled GDF-15 induction
in MFs appears to be an exploitable therapeutic approach for
regeneration immunotherapy, immunomodulation, and regula-
tion of acute exercise-induced stress responses (Gil et al., 2019).
Our findings also have implications for pathological processes in
which recurrentmuscle damage and asynchrony in repair due to
genetic conditions lead to debilitating, degenerative muscle
diseases, such as Duchenne muscular dystrophy. Therefore, it
will be of great importance to determine if GDF-15 is also a
regulator of muscle regeneration in Duchenne muscular dys-
trophy or other types of myopathies, which are most of the time




All animal experiments were performed in accordance with
ethical regulations and approved by the Institutional Animal
Care and Use Committees (IACUCs) at Johns Hopkins University
(license no. MO18C251). Animals were handled according to our
animal facility’s regulatory standards at Johns Hopkins All
Children’s Hospital, managed by Charles River Laboratories.
Mice
WT 8-wk-old BoyJ (B6.SJL-Ptprca Pepcb /BoyJ, stock #002014)
and C57BL/6J (stock #000664) control mice were obtained from
The Jackson Laboratory and bred under specific pathogen–free
(SPF) conditions. Mice were housed five per cage, kept on a
12-h light cycle (6 a.m. to 6 p.m.) in an SPF vivarium that
conforms to IACUC and Association for Assessment and Ac-
creditation of Laboratory Animal Care International specifi-
cations. Gdf15 KO mice were obtained from Dr. Se-Jin Lee at
Johns Hopkins University School of Medicine (Baltimore,
MD), Rxrafl/fl Rxrb−/−LysM-Cre mice were obtained from Pierre
Chambon (Institut de Génétique et de Biologie Moléculaire et
Cellulaire, Strasbourg, France), and mice carrying floxed alleles
of Pparγ (Pparγfl/fl LysM-Cre) were created as described pre-
viously (Szanto et al., 2010). All irradiation experiments were
performed under anesthesia in cohorts of 12 animals per ex-
periment as previously described (Patsalos et al., 2017; Giannakis
et al., 2019; Patsalos et al., 2019). Briefly, mice were anesthetized
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with a single intraperitoneal dose of ketamine/xylazine
(ketamine 80–100 mg/kg and xylazine 10–12.5 mg/kg). Irradi-
ated and BM-transplanted mice were maintained in SPF status
(autoclaved top filter cages) for the entire course of experi-
mentation. Antibiotics (amoxicillin antibiotic and clavulanic
acid [500 mg/125 mg/liter of drinking water]) were adminis-
tered in the drinking water for 4 wk after transplantation to
minimize bacterial contamination within the water source and
potentially decrease the burden of gastrointestinal bacteria.
Irradiated mice were also fed autoclaved rodent chow ad libi-
tum. Animals that undergo irradiation for BMT typically lose a
considerable amount of weight, only to gain it back relatively
quickly after successful transplantation. At our institutions,
weight loss of 20% or greater was used as a rationale for eu-
thanasia before the intended experimental end point according
to the IACUC guidelines. When necessary and for tissue col-
lection, mice were euthanized by either isoflurane overdose
(adjusted flow rate or concentration to 5% or greater) or CO2
exposure (adjusted flow rate 3 liter/min) in accordance with
Johns Hopkins University’s IACUC guidelines. When indicated,
recombinant GDF-15 (30 µg/kg) was administrated intramus-
cularly under anesthesia.
Acute sterile muscle injury
Mice (8–12-wk-old males) were anesthetized with isoflurane
(adjusted flow rate or concentration to 1.5%), and 50 µl of 10 µM
CTX (217503-1MG; EMDMillipore) was injected in the TA muscle.
Mice were brought out of anesthesia and monitored until they
were euthanized and processed at various time points. Muscles
were recovered for flow cytometry analysis at day 1 to day 4 after
injury or for muscle histology at day 8 to day 21 after injury.
Histological analysis of muscle regeneration
Muscles were removed, mounted on precut cork discs (63305; EMS)
using tragacanth gum (104792; MP Biomedicals), and snap-frozen in
nitrogen-chilled isopentane (−160°C). 8-µm-thick cryosections were
cut and stained with H&E. For each histological analysis, at least five
slides (per condition) were selected where the total regenerative
region within the CTX-injured TAmuscle was at least 70%. For each
TA, myofibers in the entire injured area were counted and mea-
sured. H&E-stainedmuscle sectionswere scannedwith theMirax or
Leica Aperio High-Definition digital slide scanner. The CSA and
necrosis (expressed as a percentage of the total number of my-
ofibers)were quantifiedwithHALO software (Indica Labs). CSAs for
these samples are reported in square micrometers. Areas of necrosis
were identified based on the following histological criteria: blurring
of cell borders, cytoplasmic fragmentation, caliber variation, cell
distances, loss of nuclei, and increased immune cell infiltration (Al-
Sawaf et al., 2014). Necrotic/phagocyted myofibers were further
defined as pink, pale, patchy fibers invaded by basophil cells (MFs).
The necrotic fiber content data presented herewere quantified using
both immunohistochemistry (Desmin staining) and histology.
BMT
Recipient congenic BoyJ mice (8 wk old) were irradiated with
11 Gy using an X-rad 320 (Precision X-ray Irradiation Systems)
x-ray unit for the ablation of the recipient BM. During
irradiation, one of the hindlimbs was shielded as described
previously (Patsalos et al., 2017). Following the irradiation, iso-
lated BM cells (in sterile RPMI-1640 medium) were flushed out
the femur; tibia and humerus from donor C57Bl/6J mice were
transplanted into the recipient mice by retro-orbital injection
(20 × 106 BM cells per mouse). This experimental BMT CD45
congenic model allows us to detect donor, competitor, and host
contribution in hematopoiesis and repopulation efficiency of
donor cells (congenic mice with CD45.1 versus CD45.2). The
CD45.1 and CD45.2 contributions were then detected by flow
cytometry, usually 8–12 wk following the BMT. In short, a cut
at the tail tip of the mice provided a drop of blood that was
placed into 0.5 ml PBS + 1% FBS + 10 U/ml heparin buffer
(samples kept on ice). The cells were directly stained by
mouse anti-mouse CD45.2-FITC (clone 104) and rat anti-
mouse GR1-PE (clone RB6-8C5) antibodies (BD PharMingen;
1/50 dilution) and incubated on ice for 30 min. After two
washes with ice-cold PBS/FBS/heparin buffer, we resuspended
the cells in 0.5–1 ml FACS Lysing solution (BD Cat #349202). We
incubated for 5 min at room temperature and then centrifuged
the cells (400 g, 5 min, 4°C). We ran the double-stained samples
on FACS (MoFlo Astrios, Cytoflex) and determined the ratio of
donor cells. The repopulation (blood chimerism) is usually >90%
gated on either the granulocyte or monocyte fraction, as
described previously (Patsalos et al., 2017).
In vivo muscle force measurement
In vivo twitch and tetanic forces were measured as described
previously (Giannakis et al., 2019). Briefly, animals were first
anesthetized with 3% vaporized isoflurane mixed with O2 and
then positioned under a heat lamp to maintain the body tem-
perature at 37°C. Fur was removed from hindlimbs using fine
electric hair clippers (Wahl). The right hindlimb was restrained
at the knee firmly with a clamp (secured to a fixed steel post),
and the foot was strapped to a footplate/force transducer with a
dual motor-arm attached (Aurora Scientific) to prevent move-
ment from the contraction of other muscle groups. Electrical
stimulations were applied across two 30-G needle platinum
electrodes placed through the skin just below the knee and be-
neath the TA muscle to stimulate the tibial nerve. In all mea-
surements, we used 0.1-ms pulses at a predetermined supramaximal
stimulation voltage. TA muscles were stimulated with a single
0.1-ms pulse for twitch force measurements and a train of
150 Hz for 0.3-s pulses for tetanic force measurements. A 2-
min rest was given to the animal while under anesthesia to allow
muscles to return to normal function after tetanus. We per-
formed five twitch and then five tetanic measurements on each
muscle, with 2–3 min of recovery between each measurement.
For these measurements, we used the 610A Dynamic Muscle
Control (DMC) software from Aurora Scientific.
In vivo grip strength
The grip strengthmeter (Harvard Apparatus) allows the study of
neuromuscular functions in rodents by determining the maxi-
mum force displayed by an animal. In this context, grip strength
changes are interpreted as evidence of motor neurotoxicity
or impairments in muscle development. The procedure was
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performed as described previously by the International Mouse
Phenotyping Consortium. Briefly, the grip strength meter is
positioned horizontally, and the animals are held by the tail and
lowered toward the apparatus. The animals are allowed to
grasp the metal grid with their hindlimbs and are then pulled
backward in the horizontal plane. The force applied to the grid
just before it loses grip is recorded as the peak tension. This
force was measured in grams. Data are visualized on the control
unit display and exported for analysis. Five consecutive grip
strength measurements for each mouse were performed with
1 min rest between measurements.
Immunohistochemistry
Tissue sections were fixed and permeabilized in ice-cold acetone
for 5 min and blocked for 30 min at 20°C (room temperature) in
PBS containing 5% BSA. Tissues were stained for 1 h at room
temperature using a primary antibody diluted in 2% BSA. For
PAX7 staining, antigen epitope retrieval was performed as de-
scribed previously (Feng et al., 2018). The primary antibodies
used for immunofluorescence were rabbit anti-laminin (Sigma-
Aldrich; L9393) at a dilution of 1/200, mouse anti-PAX7 (DSHB)
at a dilution of 1/20, rabbit anti-Desmin (Abcam; 32362) at a
dilution of 1/200, and rat anti-F4/80 (Abcam; 6640) at a dilution
of 1/200. In all cases, the primary antibody was detected using
secondary antibodies (dilution 1/200) conjugated to FITC (JIR
703–095-155) or Cy3 (JIR 711–165-152). The nuclei were coun-
terstained with 0.1–1 µg/ml Hoechst. Fluorescent microscopy
was performed using either a Carl Zeiss Axio Imager Z2 mi-
croscope or a Nikon Eclipse Ti2 inverted microscope equipped
with lasers at 488, 568, and 633 nm. Images were analyzed and
assembled using Fiji and Illustrator CS5 (Adobe).
In vivo isolation of myeloid cells from muscle
Isolation of muscle-infiltrating MFs was performed as described
previously (Giannakis et al., 2019; Patsalos et al., 2019). Briefly,
the fascia of the TA was removed, and muscles were dissociated
in either RPMI containing 0.2% collagenase B (Roche Diagnostics
GmbH) at 37°C for 1 h or by using the magnetic-activated cell
sorting (MACS) Skeletal Muscle Dissociation Kit (130–098-305;
Miltenyi) or gentleMACS Octo Dissociator, per kit instructions.
Cell homogenate was filtered through a 100-µm and a 40-µm filter,
and CD45+ cells were isolated using magnetic sorting (Miltenyi Bio-
tec). For FACS, MFs were treated with Fcγ receptor blocking anti-
bodies, 5% normal rat serum, and 5% normal mouse serum, then
stained with a combination of PE-conjugated anti-Ly6C antibody
(eBioscience; HK1.4), APC-conjugated or FITC-conjugated anti-F4/80
antibody (eBioscience; BM8), FITC-conjugated anti-Ly6G antibody
(BioLegend; 1A8), Pacific Blue–conjugated anti-MHCII antibody
(BioLegend; M5/114.15.2), and eFluor660-conjugated anti-GPNMB
antibody (eBioscience; CTSREVL). Ly6Chigh F4/80low MFs, Ly6Clow
F4/80high MFs, and Ly6Ghigh Ly6Cmed F4/80− neutrophils were
quantified. Gating strategy is shown in Fig. S1, B–D. For DC and
NK cells quantification, APC-conjugated anti-NK1.1 (BioLegend;
PK136), and PE-conjugated anti-CD11c (BD PharMingen; HL3)
antibodies were also used. In each experiment, compared samples
were processed in parallel to minimize experimental variation.
Cells were analyzed on a Cytoflex S (Beckman Coulter), BD
FACSAria III, or MoFlo Astrios EQ (Beckman Coulter) sorter, and
data analysis was performed using BD FACSDIVA and FlowJo V10
software.
Isolation and purification of mouse peripheral
blood monocytes
The monocyte purification procedure was performed as de-
scribed previously (Houthuys et al., 2010) with slight mod-
ifications. In short, the blood from C57BL/6 mice was taken by
cardiac puncture to maximize the amount of blood obtained in
an endotoxin-free manner. Up to 5.3 × 107 ± 4 × 106 white blood
cells (viability >96%) were obtained from 15 ml of blood from 15
animals after red blood cell lysis (n = 3). To minimize cell ag-
gregation and adhesion to plastic, all purifications were per-
formed at 0–4°C in PBS/BSA/EDTA (MACS buffer). For red
blood cell lysis, cells were resuspended in 0.5–1 ml FACS Lysing
solution (BD; Cat #349202), incubated for 5 min at room tem-
perature, and then centrifuged (400 g, 5 min, 4°C). For FACS and
sorting,MFs were treated with Fcγ receptor blocking antibodies,
5% normal rat serum, and 5% normal mouse serum. They were
then stained with a combination of APC-conjugated anti-Ly6C
antibody (eBioscience; HK1.4), PE/Cy7-conjugated CD11b anti-
body (BD Bioscience; M1/70), PE-conjugated Ly6G antibody
(BioLegend; 1A8), and PerCP/Cy5.5-conjugated MHCII antibody
(BioLegend; M5/114.15.2). Gating and sorting strategy are shown
in Fig. S1 A.
Differentiation of BMDMs and ligand treatments
Isolation and differentiation were completed as described earlier
(Daniel et al., 2014). Briefly, BMDMs were obtained from BM
precursor cells. Total BM was obtained from mice by flushing
femurs and tibiae BM with DMEM. Cells were cultured in
DMEM medium containing 20% FBS and 30% conditioned me-
dium of L929 cell line (enriched in CSF-1) for 6 d. MFs were
seeded at 50,000 cells/cm2 for all experiments. Media were
changed to serum-free MF media (Gibco; #12065074), and MFs
were activated with vehicle (DMSO), 0.1 μM LG268, 1 μM rosi-
glitazone, 1 μM AM580, 1 μM GW3965, or in combination in
DMEM containing 20% FBS medium for 3 h.
Primary myoblast culture and in vitro effects of GDF-15 on
myogenesis
Murine myoblasts were obtained from TA muscle and cultured
using standard conditions in DMEM/F12 (Gibco Life Technolo-
gies) containing 20% FBS and 2% Ultroser G (Pall Inc.). Briefly,
young mice’s TA muscles were opened and cleared of nerves/
blood vessels/fascia. Muscle preparations were lightly digested
with collagenase, and the resulting cells were plated, then
serially expanded. For proliferation studies, myoblasts were
seeded at 10,000 cells/cm2 on Matrigel (1/10 dilution) and in-
cubated for 1 d with 2.5% FBS medium containing GDF-15 mouse
recombinant protein (250–750 ng/ml). Cells were then fixed
with 4% PFA, incubated with anti-Ki67 antibodies (Abcam;
#15580; 1/400 dilution) for 1 h at room temperature, and sub-
sequently visualized using Cy3-conjugated secondary antibodies
(Jackson ImmunoResearch Inc.; 1/200 dilution). For differenti-
ation studies, myoblasts were seeded at 30,000 cells/cm2 on
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Matrigel (1/10) and incubated for 3 d in a mediumwith 2% horse
serum andmouse recombinant GDF-15 protein (250–750 ng/ml).
Cells were then incubated with anti-desmin antibodies (Abcam;
#32362; 1/200 dilution) in combination with a Cy3-conjugated
secondary antibody (Jackson ImmunoResearch Inc). The nuclei
were counterstained with 0.1–1 µg/ml Hoechst. Myogenic cell
fusion (calculated as the number of nuclei within myotubes di-
vided by the total number of nuclei) was evaluated as described
earlier (Saclier et al., 2013). Fluorescent microscopy was per-
formed using a Carl Zeiss Axio Imager Z2 microscope equipped
with lasers at 488, 568, and 633 nm. Images were analyzed for
proliferation and fusion index using Fiji.
SDS-PAGE and Western Blot
GDF-15 protein expression was measured using Western blot
analysis. Homogenates were prepared from frozen CTX-injected
TA muscles using a TissueLyser II (QIAGEN) and stainless-steel
beads in RIPA buffer (Abcam), with a protease and phosphatase
inhibitor cocktail (Thermo Fisher Scientific), or from primary
CD45-selected cells from CTX-injured TA muscle. Samples were
run on Bolt 4–12% Bis-Tris Plus (Invitrogen; NW04127BOX) and
subsequently transferred onto 0.45-µm polyvinylidene fluoride
membranes via a Mini Blot Wet Transfer Module (Thermo Fisher
Scientific; NW2000) for 1 h at 20 V. Membranes were blocked
with Odyssey Blocking Buffer with 0.1% Tween 20 for 1 h at room
temperature, and GDF-15 was targeted using a rabbit polyclonal
anti–GDF-15 primary antibody (Abcam; ab105738) at 1:1,000 di-
lution in Odyssey Blocking Buffer with 0.1% Tween 20 overnight
at 4°C. Secondary antibody goat anti-rabbit IgG-HRP (Santa Cruz;
sc-2030; 1/10,000) was then used for 1 h at room temperature.
Total protein was measured using REVERT total protein stain (LI-
COR) or Ponceau S solution 0.2% (SERVA; 33427.01). Bands were
visualized using an Odyssey Digital Infrared Imaging System (LI-
COR) or a BioRad ChemiDoc MP Imaging System and quantified
using Odyssey Application Software version 3.0 (LI-COR) or Bio-
Rad Image Lab Software (v6.1), respectively. For monomer de-
tection, membranes were visualized using SuperSignal West Pico
Luminol Substrate (Thermo Fisher Scientific; 34080) for 5 min
and processed using a Kodak X-Ray Film Developer. Images were
quantified using ImageJ software.
Recombinant GDF-15 production
For the production of the in-house GDF-15 protein, the mature
peptide of GDF-15 was cloned into a pET20b(+) plasmid and
produced in Escherichia coli. Recombinant mature GDF-15 was
His-tag purified, underwent endotoxin removal, was lyophi-
lized, and then was freeze-dried.
RNA isolation
Total RNA was isolated with TRIZOL reagent according to the
manufacturer’s recommendations (Zymo Research; Direct-zol
RNA MiniPrep Plus). 20 µg glycogen (Ambion) was added as a
carrier for RNA precipitation.
Real time qPCR and enhancer RNA measurements
Transcript quantification was performed by real-time RT-qPCR
using SYBR Green assays. RT-qPCR results were analyzed with
the standard delta Ct method, and results were normalized to the
expression of Ppia or Rpl32. For eRNA measurements, RNA was
DNase-treated and reverse-transcribed with the High-Capacity
cDNA Reverse Transcription Kit (Applied Biosystems) according
to the manufacturer’s protocol. Enhancer transcript quantifica-
tion was performed by qPCR reactions using SYBR green master
mix (BioRad), and eRNA levels were normalized to Ppia. mRNA
and eRNA primer sequences and locus coordinates are provided
in Table 1.
RNA-seq library preparation
cDNA libraries for RNA-seq were generated from 100–400 ng
total RNA using the TruSeq RNA Sample Preparation Kit (Illu-
mina) or NEBNext Ultra II RNA Library Prep Kit (Illumina),
according to the manufacturer’s protocol. Briefly, poly-A tailed
RNA molecules were pulled down with poly-T oligo attached
magnetic beads. Following purification, mRNA was fragmented
with divalent cations at 85°C, and cDNAwas generated by random
primers and SuperScript II enzyme (Life Technologies). Second
strand synthesis was performed, followed by end repair, single "A"
base addition, and ligation of barcode-indexed adaptors to the
DNA fragments. Adapter specific PCRs were performed to gen-
erate sequencing libraries. Libraries were size-selected with E-Gel
EX 2% agarose gels (Life Technologies) and purified by the QIA-
quick Gel Extraction Kit (QIAGEN). Libraries were sequenced on
either a HiSeq 2500 or a NextSeq 550 instrument using the
NextSeq500/550 High Output Kit v2.5. At least three biological
replicates were sequenced for each sorted population.
Gene expression data processing and analysis
RNA-seq samples of the sorted and isolated blood monocytes,
Ly6Chigh, and Ly6Clow MFs of days 1, 2, and 4 after CTX were
analyzed in parallel using the nf-core/rnaseq v3.2 pipeline (Ewels
et al., 2020). Briefly, raw single-end reads were quality-checked
by FastQC (https://github.com/s-andrews/FastQC) and aligned
to the mm10 (GRCm38) genome assembly with STAR using de-
fault parameters (Dobin et al., 2013). Genes were quantified
using Salmon (Patro et al., 2017). Normalized coverage density
tracks (bigwig files) for RNA-seq data were generated by deep-
tools and bamCoverage (Ramı́rez et al., 2016). Genes with CPM
<10 were filtered out, and only protein-coding genes were kept
for downstream analysis. Statistically significant difference was
considered false discovery rate (FDR) <0.05 fromGLM test using
R package edgeR (Robinson et al., 2010). We assessed the overall
relationship of the datasets by using multidimensional scaling
on the normalized values and hierarchical clustering on the
distance measures of Spearman correlation values and visual-
ized in R. For k-means clustering, we calculated the optimal
cluster number by evaluating the sum of squared error between
increasing number of clusters (elbow-plot on Fig. S2 C) along
with gap statistics (Fig. S2 C, inset). Next, we applied the kmeans
function on the scaled data using seven centers. For Pearson
similarity metric analysis and to find genes that follow a similar
trend and rate to Igf1, the “Find Similar Entities” feature of the
Strand NGS 3.4 software was used, with similarity cutoff set at
≥0.9. Heatmaps were generated based on scaled log2-trans-
formed CPM values using the pheatmap R package.
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GO and GSEA
GSEA was performed using hypeR (Federico and Monti, 2020). We
used the hallmark gene sets of MSigDB (Subramanian et al., 2005;
Liberzon et al., 2011; Liberzon et al., 2015) keeping significantly en-
riched terms with P < 0.05. Lists of genes were also analyzed using
the Panther tool (http://www.geneontology.org/), REACTOME
(https://reactome.org/), and the GO pathway databases for
GSEA. GOs with P values <0.05 were selected (Fisher’s exact test
with FDR correction), and results were presented according to
their −log10 P value.
IPA Upstream Regulator Analysis
To explain the biological activities of each cluster, we identified the
upstream transcriptional regulators in each module with a P value of
overlap <0.05 using the IPA Upstream Regulator Analysis (QIAGEN;
https://www.qiagenbioinformatics.com/products/ingenuity-pathway-
analysis). Regulators with at least 20 known gene targets in the an-
alyzed dataset were chosen for further analysis.
scRNA-seq
After tissue digestion and bead selection, CD45+ single-cell–sorted
suspensions were washed and resuspended in 0.04% BSA in PBS at
a concentration of at least 400 cells/µl. Cells were countedmanually
with a hemocytometer to determine their concentration. scRNA-seq
libraries were then prepared using the Chromium Single-Cell 39
reagent kit v3.1 (10X Genomics) in accordance with the manu-
facturer’s protocol. Briefly, the cells were diluted into the Chro-
mium Single-Cell A Chip to yield recovery of ∼10,000 single-cell
transcriptomes with <5% doublet rate. Following the library prep-
aration, the libraries were sequenced on the NovaSeq 6000 se-
quencer (Illumina) to produce ∼450 million reads per library and,
on average, a minimum of 40,000 reads per single cell.
scRNA-seq data analysis
scRNA-seq reads were processed and aligned to the mouse ref-
erence transcriptome (mm10) with the Cell Ranger version 3.1.0
(10x Genomics). We used CellBender to eliminate technical arti-
facts. From the gene expression matrix, the downstream analysis
was performed with R version 4.0.2 (2020–06-22). Quality con-
trol, filtering, data clustering and visualization, and the differen-
tial expression analysis were performed using Seurat (v3.2.2) R
package (Butler et al., 2018) with some custom modifications to
the standard pipeline. Genes expressed in less than three cells and
cells with <1,000 UMIs and <200 genes were removed from the
gene expression matrix. In addition, we removed any single cell
with >5% UMIsmapped tomitochondrial genes, as well as obvious
outliers in the number of UMIs (cell doublets; Fig. S1, A and B).
After log-normalizing the data, the expression of each gene was
scaled, regressing out the number of UMIs and the percent mi-
tochondrial gene expressed in each cell. We performed principal
component analysis on the gene expression matrix and used the
first 30 principal components for clustering and visualization.
Unsupervised SNN clustering was performed with a resolution of
0.35, and visualization was done using t-distributed stochastic
neighbor embedding (Becht et al., 2018). We performed a silhou-
ette analysis (R cluster package) to select an optimal SNN resolu-
tion parameter that balanced the number of expected clusters
(given known marker expression) with a maximal average sil-
houette width. Finally, differential expression analysis was ach-
ieved using Seurat’s FindAllMarkers function using a likelihood
ratio test that assumes the data follow a negative binomial dis-
tribution and only considering genes with >log2(0.25) fold-change
and expressed in at least 40% of cells in the cluster. Feature plots
were generated using the Nebulosa package (Alquicira-Hernandez
and Powell, 2020 Preprint). In the SCENICworkflow, coexpression
modules between TFs and candidate target genes are first inferred
using GENIE3 (Aibar et al., 2017; Van de Sande et al., 2020).
RcisTarget then identifies modules for which the regulator’s
binding motif is significantly enriched across the target genes and
creates regulons with only direct targets. AUCell uses the area
under the curve (AUC) to score the activity of each regulon in each
cell, thereby yielding a binarized activity matrix.
Table 1. Primers for qRT-PCR detection of eRNA and mRNA
Gene Forward primer, 59–39 Reverse primer, 59–39 Genomic coordinates
Gdf15 eRNA −2.6 kb TAGGATCCCACTTCGCCAGG TTAACCCCCAAGTGACACCC chr8: 70633546–70633793
Gdf15 eRNA −3.6 kb GACATCTCCCCTCGGGTTCTA CACTACACCACAGCACCAGC chr8: 70634857–70634974
Gdf15 mRNA GCTGTCCGGATACTCAGTCC CTTCAGGGGCCTAGTGATGTC -
Gdf3 mRNA GGGTGTTCGTGGGAACCT CCATCTTGGAAAGGTTTCTGTG -
Ppia mRNA GCGTCTCCTTCGAGCTGTTT ACCACCCTGGCACATGAATC -
Myh2 mRNA TCCAAGTTCCGCAAGATCCA GCGCATGACCAAAGGTTTCA -
Pax7 mRNA GGCACAGAGGACCAAGCTC GCACGCCGGTTACTGAAC -
Rpl32 mRNA ACATTTGCCCTGAATGTGGT ATCCTCTTGCCCTGATCCTT -
Igf1 mRNA TGGATGCTCTTCAGTTCGTG GCAACACTCATCCACAATGC -
Cd36 mRNA TTGTACCTATACTGTGGCTAAATGAGA CTTGTGTTTTGAACATTTCTGCTT -
Rxrα mRNA ACATTTCCTGCCGCTCGACTT TGATGACAGAGAAGGGCGGA -
Gpnmb v1 mRNA ACGGCAGGTGGAAGGACT CGGTGAGTCACTGGTCAGG -
Gpnmb v2 mRNA AGCCAATAGGAAACTGCCCC AACAACAGTTCCCAGCCACA -
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Mapping, normalization, and analysis of ATAC-seq
The primary analysis of ATAC-seq has been performed using the
newest version of ChIP-seq analysis command-line pipeline
(Patsalos et al., 2019; Daniel et al., 2018) including the following
steps: alignment to the mm10mouse genome assembly was done
by the Burrows-Wheeler Aligner tool (Li and Durbin, 2009), and
binary alignment map files were created by SAMTools (Li et al.,
2009). Signals (peaks) were predicted by MACS2 (Zhang et al.,
2008). Artifacts were removed according to the blacklist from
the Encyclopedia of DNA Elements (ENCODE; ENCODE Project
Consortium, 2012) and filtered for further analysis by removing
low mapping quality reads (mapping quality score <10), dupli-
cated reads, and reads located in blacklisted regions. All regions
derived from at least any two samples were united within 0.5 kb,
and those summits having the highest MACS2 peak score in any
sample were assigned to each region. Promoter-distal regions
were selected by excluding the transcription start site ± 0.5 kb
regions according to the mouse GRCm38.p1 (mm10) annotation
version. In total, we identified 57,409 peaks frommuscle-derived
MF samples. Tag directories used by HOMER (Hypergeometric
Optimization of Motif EnRichment) in the following steps were
generated with a 120-nucleotide fragment length with make-
TagDirectory (Heinz et al., 2010). Genome coverage (bedgraph
and tdf) files were generated by makeUCSCfile.pl (HOMER)
and igvtools, respectively, and used for visualization with IGV2
(Thorvaldsdóttir et al., 2013). Coverage values were further
normalized by the upper decile value detected in the consensus
regions for each sample to minimize the inter-sample variance.
Differential chromatin accessibility analysis
To identify the open chromatin regions involved in muscle-derived
MF differentiation, we compared the two end point cell populations
of this process: day 1 Ly6Chigh versus day 4 Ly6Clow. DiffBind v2.6.6
was used to identify differentially opened regions, with DESeq2
(method = DBA_DESEQ2, bFullLibrarySize = FALSE; Love et al.,
2014). An ATAC-seq region was defined as differentially changed
if the peak showed |log2 FC| >1.5 and FDR-corrected P value <0.05.
Motif analysis
De novo motif analysis of differentially opened chromatin re-
gions was performed using HOMER’s findMotifsGenome.pl (-len
12 -size 200 -dumpFasta -bits -fdr; Heinz et al., 2010). Motif ma-
trices of HOMER’s collection selected by the resulting top de
novo motifs were used to calculate motif enrichments using
HOMER’s annotatePeaks.pl program and plotted in R (Heinz
et al., 2010). Motif logos were created with seqLogo in R.
ChIP-seq analysis
The primary analysis of ChIP-seq-derived raw sequence reads
has been performed similarly as described for the ATAC-seq
analysis. Peaks were predicted by MACS2, and artifacts were
removed by BEDTools according to the blacklist of ENCODE.
Motif enrichment analyses of the ±50-bp vicinity of the
highest RXR peak summits (up to 1,000) were performed by
findMotifsGenome.pl using -mask, -len 10,12,14,16, -bits, -pre-
parse, and -homer2 parameters (HOMER). Three RXR, PPARγ,
and RNA polymerase II-pS2 ChIP-seq replicates derived from
differentiated BMDMs were analyzed by DiffBind v1.0.9 (con-
sensus peak set was formed from those peaks predicted from at
least two of six samples). RNAPII-pS2 abundance on gene bodies
(using mm10 RefSeq annotation) was calculated and tested using
package Rsubread and edgeR (P ≤ 0.05 and FC ≥ 1.5), respectively.
Statistics
ANOVA with Bonferroni correction for multiple testing was used
to determine statistical significance. Adjusted P values are stated
within the figure legends. All experiments were performed using
at least three independent experiments from distinct samples. No
repeated measures were performed. For RT-qPCR analyses, at
least three biological samples were used for each condition. For
FACS marker analysis, at least four independent samples were
analyzed, and at least 5 × 105 cells were counted for each FACS cell
population. For the histology experiments, at least 10 biological
samples were used (each animal provides two biological samples).
For the CSA distribution, two-way ANOVA was used to mark
significance for each size class. In scatter dot plots, mean and SEM
are shown in addition to individual data points. In bar graphs, bars
show themean of the indicated number of samples, and error bars
represent SEM. Student’s t tests and ANOVA analyses were per-
formed in GraphPad Prism 8 (GraphPad Software) with 95% CIs,
and P < 0.05 was considered statistically significant (*, P < 0.05;
**, P < 0.01; ***, P < 0.001; ****, P < 0.0001).
Online supplemental material
Fig. S1 shows the sorting/gating strategy for the circulating
monocytes and muscle-infiltrating MFs. Fig. S2 shows the hi-
erarchical and k-means clustering of the muscle-infiltrating MF
expression dynamics along with gene enrichment analysis and
coexpression modules for each cluster. Fig. S3 shows the GO
pathway and upstream regulator analysis of DE genes between
blood monocytes and muscle-infiltrating repair MFs and the
overlap with RXR- and PPARγ-regulated genes. Fig. S4 shows
that GDF-15 ablation allows normal muscle development and
muscle growth in uninjured animals but impacts the cellular
composition of the injuredmilieu. Fig. S5 provides technical and
quality control measures for the scRNA-seq dataset and its
downstream analysis. Table S1 provides the gene expression
changes between MF subsets. Table S2 provides the genes with
cluster indication of the k-means clustering analysis and
membership score.
Data availability
The RNA-seq data presented in this article have been deposited
in GEO under accession nos. GSE182455 and GSE164722. The
scRNA-seq data have been deposited in GEO under accession no.
GSE161467. The ATAC-seq data analyzed in this article have been
deposited in GEO under accession no. GSE129393. The ChIP-seq
data are available in GEO Superseries accession no. GSE110465
and GEO Subseries accession no. GSE107456.
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Figure S1. Circulating monocytes andmuscle-infiltrating MFs sorting/gating strategy. (A) FACS gating strategy for the analysis and sorting of circulating
monocytes. Leukocytes were CD45+-purified by magnetic bead selection and gated on forward scatter (FSC)/side scatter (SSC) to discriminate live cells, and
then markers for CD11b, Ly6G, Ly6C, and MHCII were used to isolate them. x and y axis numbers indicate the fluorescence intensity (on the log10 scale) of the
indicated fluorescent-labeled antibodies for all the plotted events. FSC and SSC axes are shown in arbitrary linear scale of increasing intensity signal.
(B–D) FACS gating strategy for the analysis and sorting of MF subsets from CTX-injured muscles at days 1 (B), 2 (C), and 4 (D). Leukocytes were CD45+-purified
by magnetic bead selection and gated on FSC/SSC to discriminate live cells, and thenmarkers for Ly6G, F4/80, and Ly6Cwere used to isolate them. x and y axis
numbers indicate the fluorescence intensity (on the log10 scale) of the indicated fluorescent-labeled antibodies for all the plotted events. FSC and SSC axes are
shown in arbitrary linear scale of increasing intensity signal. (E) Adgre1 (F4/80), Ly6c2, H2-Eb1 (MHCII), Ly6g, and Ptprc (CD45) normalized gene expression
(in log2[CPM]) in the RNA-seq datasets from sorted MF populations validates the FACS gating and sorting strategy. PE, phycoerythrin; PE/Cy7, PE-Cyanine7;
PerCP/Cy5.5, peridinin-chlorophyll-protein complex–Cyanine5.5; APC, allophycocyanin.
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Figure S2. Muscle-infiltrating MFs RNA-seq clustering (related to Fig. 1). (A) Hierarchical clustering with distance information on normalized mRNA
expression values of blood monocytes, Ly6Chigh, and Ly6Clow muscle-infiltrating MFs reflecting the overall relationship between datasets. (B) Dendrogram
using hierarchical clustering showing the relationship between RNA-seq datasets from blood monocytes, Ly6Chigh, and Ly6Clow muscle-infiltrating MFs.
(C) Elbow-plot of the sum of squares between groups with increasing number of clusters used to determine the optimal number of clusters for k-means in the
RNA-seq datasets from blood monocytes, Ly6Chigh, and Ly6Clow muscle-infiltrating MFs. The optimal number of clusters (k = 7) is indicated by the blue dotted
line. Inset shows the results of applying the “gap statistic”method for estimating the number of clusters by comparing the change in within-cluster dispersion
with that expected under an appropriate reference null distribution (the red dotted line indicates optimal number of clusters, k = 7). (D) Line plots showing the
expression dynamics of all genes per cluster (row Z-score). Centroids are represented with black lines. Color density represents the correlation of a given gene
with its centroid. Total number of genes within each cluster is indicated at the bottom right corner. (E) Co-expression signature modules detected in clusters
1 to 7 using a hypergeometric gene enrichment workflow (hypeRwith FDR <0.05 and background population gene set at 25,000). (F) Gene enrichment analysis
(REACTOME database) of the genes that are part of cluster 2. All terms shown have fold enrichment ≥2 and P value <0.001 (Fisher’s exact test with FDR
correction). (G) Gene enrichment analysis (REACTOME database) of the genes that are part of cluster 5. All terms shown have fold enrichment ≥2 and P value
<0.001 (Fisher’s exact test with FDR correction). C, cluster; D, day.
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Figure S3. GO pathway analysis of DE genes between blood monocytes andmuscle-infiltrating repair MFs (related to Figs. 2 and 5). (A) IPA Upstream
Regulator Analysis on genes participating in cluster 5. Top 35 transcriptional regulators are shown, ranked based on P value (P < 0.01; Fisher’s exact test). In
parentheses are the number of known target genes included in the cluster. Highlighted in bold are the regulators predicted to target Gdf15 based on the
literature (IPA Knowledge Base). Underline indicates the ligand-dependent nuclear receptors. (B) IPA Upstream Regulator Analysis on genes participating in
cluster 2. Top 35 transcriptional regulators with at least 10 known target genes in the cluster are ranked based on P value (P < 0.05; Fisher’s exact test with FDR
correction). (C) Gene enrichment/GO analysis of the up-regulated genes in day 4 reparatory Ly6Clow MFs versus circulating monocytes. All terms shown have P
value <0.001 (Fisher’s exact test with FDR correction). (D) Gene enrichment/GO analysis of the down-regulated genes in day 4 reparatory Ly6Clow MFs versus
circulating monocytes. All terms shown have P value <0.001 (Fisher’s exact test with FDR correction). (E) Venn diagram illustrating the overlap of DE genes (FC
≥1.5 and P value <0.05) in day 4 reparatory Ly6Clow MFs versus circulating monocytes and genes belonging to clusters 2 and 5 following the k-means clas-
sification. Percentage of overlap and number of genes are shown. Statistically significant difference was considered FDR <0.05 from GLM test. (F) Venn
diagram illustrating the overlap of PPARγ regulated genes in muscle-infiltrating MFs (FC ≥1.5 and P value <0.05 determined by hypeR) and genes belonging to
clusters 2 and 5 following the k-means classification. The number of genes is shown. The microarray dataset of PPARγ null muscle-infiltrating MFs used for this
analysis is publicly available (GEO accession no. GSE71155; Varga et al., 2016b). (G) Venn diagram illustrating the overlap of RXR-regulated genes in un-
stimulated BMDMs (FC ≥1.5 and P value <0.05 determined by hypeR) and genes belonging to clusters 2 and 5 following the k-means classification. The number
of genes is shown. The RNA-seq datasets of RXR-null BMDMs used for this analysis are deposited under GEO accession no. GSE164722.
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Figure S4. GDF-15 ablation allows normal muscle development and muscle growth in uninjured animals (related to Fig. 3). (A and B) Fiber size
repartition of regenerating muscle in WT-control and Gdf15 KOmice at days 12 (A) and 16 (B) after CTX injury (two-way ANOVA with multiple comparison test).
Insets show the average fiber CSA of regenerating muscle at indicated time points after CTX injury (n = at least 5 mice per group). (C) Average fiber CSA of
regenerating muscle in WT-control and Gdf15 KOmice at day 21 after CTX injury (n = 12 muscles per group). (D) Representative images of increased infiltration
in H&E-stained skeletal muscle (TA) from WT-control and Gdf15 KO animals at day 21 after CTX-induced injury. Arrow indicates area of persistent immune cell
infiltration. Scale bars in the upper left corner represent 100 µm. (E) Top: Representative images of H&E-stained skeletal muscle (TA) from uninjured WT-
control and Gdf15 KO animals. Bottom: Representative images of H&E-stained skeletal muscle (TA) from uninjured control–BMT and Gdf15 KO–BMT chimeras.
Scale bars in the upper left corner represent 100 µm. (F) Average fiber CSA of uninjured muscle in WT-control and Gdf15 KO animals (n = 4 mice per group).
(G) In vivo hindlimb grip strength in uninjured WT-control and Gdf15 KO adult male mice. Mean of five measurements per mouse is plotted (n = 6 mice per
group). (H) Quantification of in vivo muscle twitch force in uninjured WT-control and Gdf15 KOmice (n = 5 mice per group). (I) Quantification of in vivo muscle
tetanus force in uninjuredWT-control and Gdf15 KOmice (n = 5 mice per group). (J) Representative immunofluorescence images of regeneratingmuscles inWT-
control and Gdf15 KO animals at day 8 after injury (red marks proliferation marker Ki67, green marks MF marker F4/80, and blue indicates nuclei). Scale bars in
the upper left corner represent 100 µm. (K) Increased presence of F4/80+ cells in the Gdf15 KO at day 8 after CTX. Values are expressed as percentage of total
cells (n = 15 representative fields of view per group). (L) Quantification shows the proliferation index of F4/80+ cells. The values represent the percentage of
Ki67+ cells over F4/80+ cells in the respective field of view (n = 15 representative fields of view per group). (M) Frequency (in %) of DCs from WT-control and
Gdf15 KO mice at day 4 following CTX injury (n = 4 animals per group). x and y axis numbers indicate the fluorescence intensity (on the log10 scale) of the
indicated fluorescent-labeled antibodies for all the plotted events. (N) Representative FACS contour plots of DCs (gated as CD45+ CD11c+ F4/80− Ly6G-
MHCII+) at day 4 after CTX in WT-control and Gdf15 KO animals. x and y axis numbers indicate the fluorescence intensity (on the log10 scale) of the indicated
fluorescent-labeled antibodies for all the plotted events. AF488, Alexa Fluor 488. (O) Absolute number of infiltrating DCs in regenerating muscle from WT-
control and Gdf15 KO muscles at day 4 after CTX injury using counting beads (n = 4 animals per group). (P) Frequency (in %) of NK cells from WT-control and
Gdf15 KOmice at day 4 following CTX injury (n = 4). (Q) Absolute number of infiltrating NK cells in regenerating muscle fromWT-control and Gdf15 KOmuscles
at day 4 after CTX injury using counting beads (n = 4 animals per group). (R) Representative FACS analysis of NK cells (gated as CD45+ F4/80− Ly6G− Nk1.1+) at
day 4 after CTX in control and Gdf15 KO animals. y axis numbers indicate the fluorescence intensity (on the log10 scale) of the indicated fluorescent-labeled
antibody for all the plotted events. x axis scale is an arbitrary linear scale representing increasing intensity of forward scatter (FSC) signal. APC, allophyco-
cyanin. (S) Representative flow cytometry contour plots of inflammatory and repair MFs (without excluding Ly6G+ cells) from WT-control and Gdf15 KO at day
4 after CTX injury. Shapes indicate the gating used for cell frequency quantification (circle = neutrophils, square = Ly6Chigh inflammatory MFs, oval = Ly6Clow
repair MFs). Representative frequencies for each cell population are shown adjacent on inside each gate. x and y axis numbers indicate the fluorescence
intensity (on the log10 scale) of the indicated fluorescent-labeled antibodies for all the plotted events. APC, allophycocyanin; PE, phycoerythrin. In all graphs,
bars and lines represent mean ± SEM. Exact P values were determined using unpaired Student’s t test unless otherwise noted. *, P < 0.05; **, P < 0.01.
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Figure S5. Technical and quality control measures for scRNA-seq dataset and its analysis (related to Fig. 7). (A) Violin plots representing the (upper left)
number of UMIs, (middle left) genes per cell, and (lower left) mitochondrial gene percentage of all cells before quality control filtering and clustering. Red lines
indicate the filtering parameter values. Box plots representing the (upper right) number of UMIs, (middle right) genes per cell, and (lower right) mitochondrial
gene percentage per cluster of the cells passing the quality control filtering. The annotated cell populations are color-coded as in Fig. 7 A, and individual cells
are shown in black dots. (B) Silhouette analysis of SNN clustering resolution parameter. Top: Box-and-whisker plot representing the average silhouette width
as a function of SNN resolution parameters. Bottom: Number of clusters identified as a function of SNN resolution parameter. The red box plot and dot
correspond to the SNN parameter value (0.35) chosen for cluster annotation and all subsequent analyses. (C) Expression heatmap (row Z-score) for top marker
genes identified in the eight CD45+ non-MF subpopulations at day 4 after CTX classified by SNN. Fibroblast-like cell genes did not pass the unique marker
selection criteria (>85% expression in the cells of the cluster and <35% expression in other clusters) to analyze. The columns represent cells and are organized
by cell type (color-coded as in A). (D) Ranked expression of all genes (n = 15,244) in the day 4 Ly6Clow RNA-seq dataset in log2 CPM reads mapped (CPM >3).
This figure illustrates that the expressions of predicted GFEM marker genes (Igf1, Gpnmb, Cd36, Rxrα, and Gdf15) are among the highest expressed genes and
well above the median expression (blue line) of all genes in this repair MF dataset.
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Table S1 and Table S2 are provided online as separate Excel files. Table S1 shows that gene expression changes between MF subsets
corresponding to the maturation from circulating monocytes to Ly6Chigh inflammatory MFs, between day 1 and day 4 transition
from Ly6Chigh inflammatory to Ly6Clow repair MFs, and between the two ends of the differentiation spectrum (blood monocytes
versus day 4 repair MFs). Table S2 shows gene lists with cluster indication of the k-means clustering analysis and membership score
(indicates how closely they correlate/match with the cluster core) that revealed the dynamically changing transcriptomic profile of
immune cell subsets after CTX injury (related to Fig. 1 E).
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